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ABSTRACT OF THE DISSERTATION
PREDICTORS OF CERVICAL CANCER SCREENING AND PHYSICIAN
RECOMMENDATIONS AMONG WOMEN IN THE UNITED STATES USING
CURRENT SCREENING GUIDELINES
by
Vincy Samuel
Florida International University, 2018
Miami, Florida
Professor Nasar U. Ahmed, Major Professor
In 2015, there were 257,524 women with cervical cancer (CC) in the United
States (U.S.). CC is preventable; screening detects early-stage cancer when treatment is
most successful. This study aimed to identify predictors for CC screening adherence
among U.S. women, describe predictors for screening adherence by marital status, and
examine physician recommendation for CC screening and adherence to those
recommendations. Predictors were grouped as demographic, acculturation, access to
care, chronic conditions, and health behaviors. Descriptive analyses were performed on a
sample of 10,667 women from the 2015 National Health Interview Survey, and multiple
logistic regression models determined predictors of CC screening adherence, physician
recommendations, and adherence to physician recommendations.
Overall, 81.7% (95%CI=80.7-82.7%) of U.S. women adhered to CC screening
guidelines. Adherence declined with increasing age after 39 years old. Never married
women (adjusted odds ratio[aOR]=0.67, CI=0.56-0.79) or current smokers (aOR=0.70,
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CI=0.59-0.84) had lower odds, while college-educated women had greater odds
(aOR=1.38, CI=1.14-1.67) of CC screening adherence.
Among unmarried women, 78.6% adhered to CC screening. Unmarried women
who were unemployed (aOR=0.48, CI=0.38-0.62), had no physician visits (aOR=0.58,
CI=0.40-0.85), no usual source of care (aOR=0.67, CI=0.50-0.89), never heard of HPV
(aOR=0.59, CI=0.46-0.76), never received HPV vaccine (aOR=0.50, CI=0.34-0.75), no
birth control use (aOR=0.33, CI=0.23-0.47), no flu shot (aOR=0.62, CI=0.48-0.80), and
perceived low breast cancer risk (aOR=0.66, CI=0.47-0.92) had lower odds of adherence.
Among women with a physician, 55.6% received screening recommendations.
Race/ethnicity, access to care, HPV knowledge and vaccine receipt, age when first child
was born, and flu shot were significant predictors of physician recommendation for CC
screening. Significant predictors of adherence to physician recommendation included
education, employment, English proficiency, outpatient clinic visits, usual source of care,
age when first child was born, birth control, alcohol use, smoking status, flu shot, and
health status.
Based on our results, two levels of intervention should be explored. First,
targeted interventions are needed for women who are unmarried, have low socioeconomic status, and limited access to care to reduce cervical cancer risk. Second,
interventions for physicians to increase screening recommendations to all eligible women
are needed to improve national screening rates.
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CHAPTER I.
INTRODUCTION
Overview
Epidemiology of cervical cancer
Cervical cancer is one of the most preventable cancers. This cancer is the fourth
most common cancer among women worldwide, and among the top causes of cancer
death. Approximately 85% of cervical cancer cases occur in less-developed regions
(International Agency for Research on Cancer, 2016). Previously one of the most
common cancers among women in the United States, cervical cancer now ranks number
21 among common types of cancer, with cervical cancer representing only 0.8% of all
new cancer cases (National Cancer Institute [NCI], n.d.).
In the United States from 2009 to 2013, the incidence rate of cervical cancer was
7.5 per 100,000 women per year, and the mortality rate was 2.3 per 100,000 women. The
lifetime risk of developing cervical cancer was 0.6 percent of women (NCI, n.d.).
Hispanic women had the highest incidence of cervical cancer, followed by non-Hispanic
Black, White, American Indian/Alaska Native, and Asian/Pacific Islander women. NonHispanic Black women had the highest mortality rate, followed by Hispanic, Asian/P
etacific Islander, non-Hispanic White, and American Indian/Alaska Native women
(Centers for Disease Control and Prevention [CDC], 2015).
Cervical cancer rates also vary by state. In 2012, Arizona, Arkansas, District of
Columbia, Florida, Kentucky, Louisiana, Mississippi, Missouri, Tennessee, Texas, and
Wisconsin had the highest incidence rates (8.2 to 9.6 per 100,000). Alabama, Arkansas,
District of Columbia, Florida, Georgia, Mississippi, Oklahoma, Texas, and West Virginia
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had the highest mortality rates (2.8 to 5.3 per 100,000) (CDC, 2014). Variations in
incidence and mortality rates by state may be attributed to differences among racial and
ethnic populations, differences in populations and health behaviors, differences in
medical care, and the influence of aging (U.S. Department of Health and Human
Services, 2018).
In 2010, the annualized mean net cost of care for cervical cancer in women under
65 years of age was $54,209 in the initial year after diagnosis and $1,425 between the
initial year and the last year of life (Mariotto, Yabroff, Shao, Feuer, & Brown, 2011).
Most private insurance companies, public employee health plans, and Medicaid offer
coverage and reimbursement for Pap testing (American Cancer Society [ACS], 2016).
For women without insurance, programs such as the National Breast and Cervical Cancer
Early Detection Program provide access to cervical cancer screening and diagnostic
testing for low-income, uninsured, and underserved women (CDC, 2016).
The risk of cervical cancer increases with smoking, positive HIV status, use of
oral contraceptives for five or more years, giving birth to three or more children, and
having multiple sex partners (CDC, 2015). Cervical cancer is the most common type of
human papillomavirus (HPV)- related cancer, and almost all cervical cancers are caused
by HPV. HPV infections may clear on its own, but some infections persist and cause
cellular changes, which can lead to genital warts or cancers (NCI, 2015).

Prevention
Most cervical cancer cases could be prevented by primary prevention with the
HPV vaccination, which is recommended for preteens at 11 to 12 years of age in order to
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protect them from being exposed to HPV. The HPV vaccine is recommended for men
and women who did not receive or finish the HPV vaccine series until they reach the ages
21 and 26, respectively (CDC, 2015). In 2014, 40.2% of women and 8.2% of men 19 to
26 years of age reported receiving at least one dose of the HPV vaccine (CDC, 2016).
Therefore, there is still a large part of the population that has not been fully vaccinated
with the HPV vaccine.
Cervical cancer is highly preventable when screening and follow-up
recommendations are adhered to (CDC, 2015). Up to 93% of cervical cancer cases can
be prevented through screening and HPV vaccination (CDC, 2014). If cervical cancer is
diagnosed at an early stage, it is treatable and associated with long term survival (CDC,
2015). Cervical cancer is a slow-growing cancer (National Cervical Cancer Coalition
[NCCC], 2016).
Secondary prevention through cervical cancer screening identifies cervical
abnormalities. Cervical cancer cases and deaths have decreased over the last 40 years
due to women receiving regular Pap tests (CDC, 2015). However, from 2008 to 2010,
cervical cancer screening rates declined slightly (Brown et al., 2014). Additionally, the
proportion of 18 year-old women who reported ever having a Pap test decreased from
approximately 50% in 2000 to 38% in 2010 (Roland et al., 2013). According to the U.S.
Preventive Services Task Force, a Pap test is recommended for women between the ages
of 21 and 65 years old who have not had a hysterectomy. Recommendations regarding
the frequency of cervical cancer screening have changed over the years (ACS, 2018).
Since 2012, a Pap test is recommended every three years, as compared to more frequently
in the years prior to 2012 (Table 1). Cervical cancer screening is only recommended
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every five years if a Pap test and an HPV test are conducted as part of a co-testing
algorithm. In 2018, the U.S. Preventive Services Task Force recommended screening
with high risk HPV testing alone every five years. These recommendations apply to
women who have not received a diagnosis of a high-grade precancerous cervical lesion or
cervical cancer, women without in utero exposure to diethylstilbestrol, or women who are
HIV negative and not otherwise immunocompromised (U.S. Preventive Services Task
Force [USPSTF], 2018).
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Table 1: History of recommendations for the early detection of cervical cancer in women
without symptoms
Dates

Test

Age

Frequency

Pre
1980

Pap test

Not specified

As part of a regular check-up

1980 1987

Pap test

20 and over; under 20 if
sexually active

Yearly, but after 2 negative exams 1 year
apart, at least every 3 years

Pelvic
exam

20 – 39

Every 3 years

40 and over

Yearly

Pap test

18 & over or sexually
active

Yearly, but after 3 consecutive normal
exams, less frequently at the discretion of
the doctor

Pelvic
exam

18 & over or sexually
active

Yearly

Pap test

Start 3 years after first
vaginal intercourse but
no later than 21

Yearly with conventional Pap test or every
2 years with liquid-based Pap test

30 and over

After 3 normal results in a row, screening
can be every 2 to 3 years. An alternative is
a Pap test plus HPV DNA testing every 3
years.*

70 and over

After 3 normal Pap tests in a row within the
past 10 years, women may choose to stop
screening**

Not specified

Discuss with health care provider

1987 2002

2003 2012

Pelvic
exam

5

2012 20181

Pap test

21 - 29

Every 3 years*

Pap test
plus HPV
DNA test

30 - 65

Every 5 years*
An alternative is screening with a Pap test
alone every 3 years*

Over 65

A woman should stop screening unless she
had a serious cervical pre-cancer or cancer
in the last 20 years

21 - 29

Every 3 years*

30 - 65

Every 5 years*
An alternative is screening with a Pap test
alone every 3 years*

Over 65

A woman should stop screening unless she
had a serious cervical pre-cancer or cancer
in the last 20 years

2018 - Pap test
Present
Pap test plus
HPV DNA
test
OR
hrHPV test

*Doctors may suggest a woman be screened more often if she has certain risk factors,
such as a history of DES exposure, HIV infection, or a weak immune system
**Women with a history of cervical cancer, DES (diethylstilbestrol) exposure, or who
have a weak immune system should continue screening as long as they are in reasonably
good health
1
These guidelines are not meant to apply to women who have been diagnosed with
cervical cancer. These women should have follow-up testing as recommended by their
healthcare team.
Sources: American Cancer Society (2018). History of ACS recommendations for the
early detection of cancer in people without symptoms. Retrieved from
https://www.cancer.org/health-care-professionals/american-cancer-society-preventionearly-detection-guidelines/overview/chronological-history-of-acs-recommendations.html.
U.S. Preventive Services Task Force (2018). Final recommendation statement: Cervical
Cancer screening. Retrieved from
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStateme
ntFinal/cervical-cancer-screening2.
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The five-year observed survival rate decreases as the disease progresses. The
five-year survival rate is 93% at stage 0, 93% at stage IA, 80% at stage IB, 63% at stage
IIA, 58% at IIB, 35% at stage IIIA, 32% at stage IIIB, 16% at IVA, and 15% at stage
IVB. These survival rates can be improved through adherence to follow-up care (ACS,
2016).
Cervical cancer screening provides the best chance of identifying the cancer at an
early stage, which is when treatment will be most successful. Prior to becoming cancer,
abnormal cervix cell changes occur, which can also be identified through screening
(ACS, 2014). Additional tests such as repeat Pap test or co-test, HPV test, colposcopy,
biopsy, endocervical sampling, and endometrial sampling may be performed, depending
on age and initial Pap test results (American Congress of Obstetricians and
Gynecologists, 2016). Treatment during this pre-cancerous change can prevent it from
becoming cervical cancer. If the changes in cervical cells are moderate or high-grade,
treatment such as loop electrosurgical excision procedure, cryotherapy, laser therapy, or
conization may be indicated to prevent cancer. If the pre-cancerous cell changes progress
to cervical cancer, tertiary prevention through treatment of invasive cancer would be
indicated (ACS, 2014). Follow-up to any abnormal results will allow for appropriate
diagnosis and subsequent treatment.

Follow-Up
Although screening is one of the most important elements in the reduction of
cervical cancer incidence and mortality, timely follow-up care for abnormal lesions is just
as important (Kaplan et al., 2000). Every year in the United States, approximately two to
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three million women learn that they have an abnormal Pap result (Hunt, 2002). In order
to sufficiently reduce the incidence and mortality of cervical cancer, an abnormal Pap test
requires a follow-up visit, diagnosis, and treatment (Yabroff, Kerner, & Mandelblatt,
2000). Therefore, it is necessary to obtain a confirmatory follow-up Pap test if an
abnormality is detected. However, many women fail to obtain the necessary follow-up
care (Eggleston, Coker, Prabhu, Cordray, & Luchok, 2007). Women who do not receive
the appropriate follow-up forfeit the benefits of early treatment (Melnikow, 1999). A
delay in follow-up visits increases the risk of developing cervical cancer or being
diagnosed with an advanced stage of the disease. If abnormalities are detected early
enough and the necessary follow-up visits and treatment are adhered to, there is close to a
100% survival rate. Among women with invasive cervical carcinomas, 13% can be
attributed to lack of follow-up after abnormal Pap results (Eggleston et al., 2007).
Despite this, approximately 20% to 50% of women with abnormal Pap results do not
comply with follow-up care. Consequently, there are still many women who are being
diagnosed with and even dying from a preventable disease (Kaplan et al., 2000).
Factors associated with non-adherence to Pap screening guidelines include lack of
a usual source of care and health insurance, income and educational status, obesity,
smoking, immigrant status, and foreign birth (Nelson, Moser, Gaffey, & Waldron, 2009).
Among women with an abnormal Pap smear, those perceived to have low literacy by
their physician were more likely to not follow-up (Lindau, Basu, & Leitsch, 2006).
There is great variation in the rates of follow-up across different populations and
settings. Approximately 7% to 49% of women with abnormal results do not follow-up
with the necessary diagnostic tests (Yabroff et al., 2000). Characteristics associated with
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women who do not follow-up after abnormal Pap tests are young age, low socioeconomic
status, and minority classification. Minority women have the lowest rates of completing
a follow-up (Abercrombie, 2001). Minority women with low income are the least likely
to comply with follow-up care (Hunt, 2002). About 80% of low-income women do not
adhere to the recommended follow-up treatment (Engelstad et al., 2001). Poverty is the
most common factor for not following up after abnormal results (Saslow et al., 2007).
Some barriers that these women may face when being told that they need a follow-up
exam are their understanding of how abnormal results can affect them, their beliefs about
their risk of having cancer, how much they believe that following up can potentially help
to prevent cancer and improve their survival, and costs associated with follow-up care.
Furthermore, some women may prefer not to hear that something may truly be wrong
with them and may opt to not find out (Ell et al., 2002). In a systematic literature review
with the outcome as adherence to follow-up after an abnormal Pap test, African American
women were not as likely to obtain the appropriate follow-up as compared to other
ethnicities (Benard et al., 2005; Eggleston et al., 2007; Engelstad et al., 2005).
Inconsistent evidence for associations between race, income, and age and screening has
been found (Eggleston et al., 2007).

Research aims and objectives
Aim 1: To describe predictors for cervical cancer screening adherence using current
guidelines among a sample of nationally representative women.
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Objective 1a: Describe demographic, acculturation, access to health care, and
health behavior and knowledge factors associated with cervical cancer screening
adherence.
Objective 1b: Describe demographic, acculturation, access to health care, and
health behavior and knowledge factors for cervical cancer screening adherence by
race/ethnicity.

Aim 2: To assess the association of marital status with cervical cancer screening
adherence using current guidelines among a sample of nationally representative women.
Objective 2a: Describe demographic, acculturation, access to health care, and
health behavior and knowledge factors for cervical cancer screening adherence among
married and unmarried women.
Objective 2b: Describe demographic, acculturation, access to health care, and
health behavior and knowledge factors for cervical cancer screening adherence among
unmarried women by race/ethnicity.

Aim 3: To explore the gap between physician recommendation of cervical cancer
screening and adherence to physician recommendation.
Objective 3a: Explore demographic, acculturation, access to health care, and
health behavior and knowledge predictors for physician recommendation.
Objective 3b: Explore demographic, acculturation, access to health care, and
health behavior and knowledge predictors for adherence to physician recommendation.
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Objective 3c: Explore the reasons for not adhering to cervical cancer screening
after physician recommendation.

Public health significance
Many studies on cervical cancer screening focus on specific geographic regions or
racial/ethnic groups (Hatcher, Studts, Dignan, Turner, & Schoenberg, 2011; Ji, Chen,
Sun, & Liang, 2010; Miranda-Diaz, Betancourt, Ruiz-Candelaria, & Hunter-Mellado,
2016; Paskett et al., 2010; Sadler et al., 2010; Schoenberg, Studts, Hatcher-Keller, Buelt,
& Adams, 2013). In addition, few studies use the most current screening guidelines in
defining adherence (Watson, Benard, King, Crawford, & Saraiya, 2017; White et al.,
2017). This study will add to the literature by using the most current screening guidelines
to explore predictors for screening adherence and physician recommendation in a large
nationally representative sample of women. The results of this study can then be used in
determining which populations to target to improve cervical cancer screening rates.
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CHAPTER II.
LITERATURE REVIEW

Overview
The literature search for this study included a comprehensive review of scientific
articles in English language from 2000 to 2017 in the following databases: MEDLINE,
PubMed, and CINAHL. Medical subject headings and keywords used included “cervical
cancer”, “Pap”, “cervical cancer screening”, “marital status”, “unmarried”, “never
married”, “physician recommendation”, “doctor recommended”, among others and from
all years. Reference lists of relevant articles were reviewed to identify additional articles.

Predictors of cervical cancer screening
Demographics
Sociodemographic factors have been shown to be predictors of cervical cancer
screening (Miles-Richardson, Allen, Claridy, Booker, & Gerbi, 2017). In analyses of the
2000 National Health Interview Survey, age, education attainment, and health insurance
were associated with cervical cancer screening (Meissner, Yabroff, Dodd, BallardBarbash, & Berrigan, 2009). Low family income, low educational level, and being
unmarried were associated with lower rates of Pap testing (Hewitt, Devesa, & Breen,
2004). Predictors for never having been screened for cervical cancer included Hispanic
race, never being married, living below poverty level, fewer than 12 years of education,
65 years of age or older, and unemployment. Some of these predictors changed when
analyzing those who had not been screened recently (Calle, Flanders, Thun, & Martin,
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1993). In addition, recent studies have shown that being non-Hispanic white reduced the
likelihood of cervical cancer screening (Miles-Richardson et al., 2017).
There are racial and ethnic differences in the association of these demographic
factors with cervical cancer screening. Hispanic and other race women were more likely
(11.1% and 14.7%, respectively) to never have a Pap test than non-Hispanic white
women (5.0%) or black women (5.8%) (Chen, Kessler, Mori, & Chauhan, 2012). Among
American Indian and Alaska Native women, higher educational level, income, presence
of one or more chronic medical conditions, being 25 to 39 years of age, and having been
ever married predicted Pap test use (Schumacher et al., 2008). Among Korean American
women, correlates of regular Pap testing included knowledge of guidelines, physician
recommendation, having health insurance, and having family or friends who also receive
Pap tests (Juon, Seung-Less, & Klassen, 2003). Among Vietnamese Americans, being
married, having a higher education level, having a female physician, having a respectful
physician, requesting a Pap test, and physician recommendation were associated with
receipt of a Pap test (Nguyen, McPhee, Nguyen, Lam, & Mock, 2002). Among Thai
women in Northern California, physician recommendation, insurance status, and primary
language were predictors of Pap testing (Tsui & Tanjasiri, 2008). Similarly, cervical
cancer screening patterns have been studied among other subgroups. According to the
Health Information National Trends Survey, women with health insurance were more
likely to adhere to cervical cancer screening than women without health insurance
(Nelson et al., 2009). Among non-Hispanic white and black women, insurance was
associated with increased likelihood of receipt of a Pap smear (Hirth, Laz, Rahman, &
Berenson, 2016).
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Women living in rural areas may face barriers to receiving cervical cancer
screening. Among farm women from three states, non-adherence to Pap testing increased
with age and decreased with education. Up-to-date Pap testing was positively associated
with obtaining a mammogram or breast examination in the past and being married
(Carruth, Browning, Reed, Skarke, & Sealey, 2006). Among Appalachian women, those
who rarely or never had breast cancer screening were likely to be rarely or never screened
for cervical cancer as well (Schoenberg et al., 2013). In two rural Oregon communities,
women over 55 years of age with co-morbidities such as arthritis, diabetes mellitus, and
hypertension were less likely to be up-to-date for cervical cancer screening as compared
to women without chronic conditions (Liu et al., 2014).
Region of residence within the United States has also been shown to be a
predictor of cervical cancer screening. Women residing in the West region of the United
States were less likely to have had cervical cancer screening, while women residing in the
Southern region of the United States were more likely (Miles-Richardson et al., 2017).
Most surveys ask women to select their marital status (Clark et al., 2009). Marital
status has been determined to be associated with cancer screening participation, such as
for colorectal cancer screening (El-Haddad, Dong, Kallail, Hines, & Ablah, 2015). In
addition, marital status impacts cancer outcomes (Aizer et al., 2013). Previous studies
have shown that unmarried women were more likely to be diagnosed with a late stage of
cervical cancer (Saghari, Ghamsary, Marie-Mitchell, Oda, & Morgan, 2015).
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Acculturation
Among recent immigrants, 73% reported having a Pap smear in the previous two
years as compared to 89% of U.S. born women. Uninsured U.S. born women were more
likely to have a Pap smear than uninsured recent immigrant women (Carrasquillo & Pati,
2004). Among Chinese American immigrants, having insurance or a regular healthcare
provider had better odds of Pap test use and adherence (Lee-Lin et al., 2007).
African American women have been shown to be three times more likely to selfreport undergoing a current Pap smear than African-born women (Forney-Gorman &
Kozhimannil, 2016). Older Chinese American women with more traditional cultural
views were less likely to be screened regularly, and those with higher English proficiency
were more likely to have received regular Pap tests as compared to women with lower
proficiency (Ji et al., 2010). Cultural beliefs about the etiology of cervical cancer affect
Pap testing among immigrant women (McMullin, De Alba, Chavez, & Hubbell, 2005).

Access to Care and Utilization
Private health insurance and a usual source of care have been shown to have a
bigger impact on cervical cancer screening adherence as compared to being uninsured
and having no usual source of care (White et al., 2017 and Watson et al., 2017). At least
one doctor’s visit in the last year has been demonstrated to be associated with screening
adherence (Ashok, Berkowitz, Hawkins, Tangka, & Saraiya, 2012; Nelson et al., 2009).
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Chronic Conditions
There has been conflicting findings on the association between chronic diseases
and breast, cervical, and colorectal cancer screenings. Some studies have found that
chronic conditions such as diabetes are a barrier to cancer screening, while other studies
have found that chronic diseases increase the likelihood of cancer screening adherence
(Brown, Hossain, & Forrester, 2013; Liu et al., 2014; Lukin et al., 2012). Pap testing
compliance among women with and without cardiovascular disease was similar.
Myocardial infarction was associated with reduced odds of Pap test compliance (Guo,
Hirth, & Berenson, 2015). A study conducted in Oregon found that women with
arthritis, diabetes mellitus, and hypertension were less likely to adhere to cervical cancer
screening compared with women without chronic conditions (Liu et al., 2014). Among
American Indian and Alaska Native women, presence of one or more chronic medical
conditions was one of the predictors of Pap test use (Schumacher et al., 2008).

Health Behaviors and Knowledge
It has been found that lifestyle factors and behaviors, including obesity, dietary
factors, alcohol intake, physical activity, oral contraceptives, and smoking affect risk of
gynecological cancers (Rieck & Fiander, 2006). Health status can include measures such
as life expectancy, physical and mental health, self-assessment of health, physical activity
and chronic illnesses (Office of Disease Prevention and Health Promotion [ODPHP],
2018). While studies have shown associations between health status and cancer
screening, the findings vary. According to the 2000 National Health Interview Survey,
health behavior patterns including usual source of care were associated with cervical
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cancer screening. Usual source of care was the strongest correlate of Pap testing
(Meissner et al., 2009). Among women 18 to 29 years old, usual source of healthcare and
current birth control use increased the chances of having a Pap test within the last 12
months (Roland et al., 2013). No primary care provider and lack of usual source of care
were associated with lower rates of Pap testing (Hewitt et al., 2004). Adherence to Pap
testing is also associated with normal body mass index, being a non-smoker, and no
mood disturbance (Nelson et al., 2009).
Some studies have shown an association between higher levels of physical
activity and higher rates of cancer screening. In addition, increased physical activity is
associated with higher odds of Pap testing among American Indian women (Muus et al.,
2012). Women with a normal BMI were more likely to adhere to regular Pap testing
compared with obese women (Nelson et al., 2009). Women with BMIs greater than 40 in
the United States were less likely to have a Pap test within three years, and women with
BMIs >30 were less likely to adhere to physician recommendation for a Pap test
(Ferrante, Chen, Crabtree, & Wartenberg, 2007). Non-Hispanic black women with BMIs
between 25 and 30 were less likely to receive a Pap smear than black women with BMIs
< 25 (Hirth et al., 2016). A systematic review showed an inverse association between
obesity and cervical cancer among non-Hispanic white women (Maruthur, Bolen,
Brancati, & Clark, 2009). Underweight women, overweight women, and obese women
are more likely to delay Pap testing by more than two years compared with women with
normal weight (Fontaine, Heo, & Allison, 2001). A higher proportion of obese nonHispanic white women compared with women of normal weight reported not undergoing
Pap testing due to putting it off, being embarrassed, or discomfort. Among women who
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did not undergo screening, obese women were just as likely as women with normal
weight to receive a physician recommendation for Pap testing (Wee, Phillips, &
McCarthy, 2005). Studies have shown that lack of physician recommendation to receive
a Pap smear may lead to underutilization of Pap smears (Coughlin, Breslau, Thompson,
& Benard, 2005).
History of family cancer has had a positive association with cancer screening in
some studies (Bostean, Crespi, & McCarthy, 2013; Carney et al., 2013; Qin, White,
Sabatino, & Febo-Vazquez, 2018; Shah et al., 2007). Non-Hispanic white and black
women with a family history of cancer were 42% more likely to have had a recent Pap
test than those without a family history of cancer, and non-Hispanic black women with a
family history of cancer were more likely to have had a recent Pap test than non-Hispanic
white women with or without a family history of cancer (Williams, Reiter, Mabiso,
Maurer, & Paskett, 2009). In contrast, a population-based study on women in
Southeastern United States showed no association between family history of cancer and
cervical cancer screening (Bellinger et al., 2013).
Systematic reviews have shown a positive association between education and
cervical cancer screening (Damiani et al., 2015), as well as between health literacy and
cervical cancer (Kim & Han, 2016). Educational attainment has been shown to have a
significant correlation with knowledge of cervical cancer risk factors (Akinlotan et al.,
2017). Many studies regarding education, knowledge, and perceptions focus on specific
ethnic groups. Korean American women with low education levels and low English
proficiency have lower rates of Pap testing than those with high education levels and
English proficiency. The most common reason for lack of regular Pap testing among the

22

Korean American women studied was the belief that it was not necessary if no symptoms
were present (Juon et al., 2003). Cancer education has been shown to be an important
predictor of cervical cancer screening among uninsured, urban Hispanic women (Buki,
Jamison, Anderson, & Cuadra, 2007).
One study found that absolute and comparative risk perceptions were not
significant predictors of cervical cancer screening adherence, but risk perception had an
indirect effect on screening through cancer worry. As women’s risk perception
increased, their worry of developing cancer also increased, which was associated with
increased screening adherence (Zhao & Nan, 2016). Recent cervical cancer screening
has been shown to be associated with knowledge of cancer risk factors and perceptions of
cancer survival (Pearlman, Clark, Rakowski, & Ehrich, 1999).
Adherence to Pap testing is associated with normal body mass index, being a nonsmoker, no mood disturbance, and being knowledgeable about Pap testing and human
papillomavirus infection (Nelson et al., 2009).
Predictors for never having been screened for cervical cancer are residence in a
central city or the Northeast. Some of these predictors change when analyzing those who
had not been screened recently (Calle et al., 1993). Among African Americans and
Hispanics in three urban public housing communities in Los Angeles, 62% had received
cervical cancer screening within the past year, and 29% stated that no health care
provider recommended cervical cancer screening to them. Affordability, continuity of
care, and physician recommendation predicted adherence to cervical cancer screening
(M. Bazargan, S. Bazargan, Farroq, & Baker, 2004).
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The PRECEDE-PROCEED Model
The PRECEDE/PROCEED model integrates social, epidemiologic, behavioral,
environmental, education, and organizational perspectives of health concerns.
PRECEDE stands for predisposing, reinforcing, and enabling constructs in
educational/environmental diagnosis and evaluation. PROCEED stands for policy,
regulatory, and organization constructs in educational and environmental development.
The predisposing, reinforcing, and enabling factors are contributing factors that influence
behavioral and environmental change. Predisposing factors include knowledge, attitudes,
beliefs, and some sociodemographic characteristics. Enabling factors include cost,
transportation, and environmental issues. Reinforcing factors include social support,
physician/patient relationship, and peer influence (Hatcher et al., 2011; Ji et al., 2010).
In this study, predisposing, enabling, and reinforcing factors were assessed as
predictors of cervical cancer screening. Predisposing factors included age, race/ethnicity,
education, chronic conditions, HPV knowledge, age when first child born, perceived risk
of breast cancer, and perceived health status (Bautista, Vila, Uso, Tellez, & Zanon, 2006;
Chen, Yamada, & Smith, 2014; Palli, Mehta, & Aparasu, 2012; Studts, Tarasenko, &
Schoenberg, 2013). Enabling factors included employment status, acculturation, and
access to care and utilization (Chen et al., 2014; Palli et al., 2012; Palmer, Midgette, &
Dankwa, 2008; Studts et al., 2013). Reinforcing factors included marital status and
physician recommendation (Studts et al., 2013).
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Figure 1: The PRECEDE/PROCEED Model

Source: McKenzie et al., 2008
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Gaps in knowledge about cervical cancer screening among women in the U.S.
First, few studies are available that used recent and robust national data on
cervical cancer screening (Miles-Richardson et al., 2017; Watson et al., 2017; White et
al., 2017). Many studies explore specific races/ethnicities, geographic regions, age
groups, and other demographic characteristics, but they are not generalizable to all U.S.
women who fit the criteria for cervical cancer screening (Fedewa, Sauer, DeSantis,
Siegel, & Jemal, 2017; Guo et al., 2015; Kepka et al., 2014; Roland et al., 2013).
Second, few national studies among United States women used the most current
screening guidelines of Pap test only or Pap/HPV co-testing in defining adherence
(Watson et al., 2017; White et al., 2017). Finally, limited information is available on
cervical cancer screening among unmarried women, physician recommendations for
cervical cancer screening, and adherence to physician recommendations (Clark et al.,
2009; Coughlin et al., 2005; De Alba & Sweningson, 2006; Hanske et al., 2016; Politi,
Clark, Rogers, McGarry, & Sciamanna, 2008).
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CHAPTER III.
METHODOLOGY
Overview
This study used cross-sectional secondary data from the 2015 National Health
Interview Survey, a nationally representative survey sample of the civilian
noninstitutionalized United States population, to explore predictors of cervical cancer
screening among women aged 21 to 65 years and among unmarried women compared to
married women. This study also assessed predictors of physician recommendation for
cervical cancer screening and adherence to physician recommendation.

Sample and description of data source
The data source for this study was the 2015 National Health Interview Survey
(NHIS) (National Center for Health Statistics, CDC, 2017). The National Health
Interview Survey is a cross-sectional household interview survey with a multistage area
probability design that allows for representative sampling of household and noninstitutional group quarters. The sampling plan is a sample of clusters of addresses in
primary sampling units, which consist of a county, small group of contiguous counties, or
a metropolitan statistical area (CDC, 2018).
The NHIS questionnaire had a core set and supplemental sets of questions. The
core questionnaire consisted of household, family, sample adult, and sample child
components. The household component consisted of demographic information on all
individuals in the household, and the family component collected additional demographic
and health information on each family member in the household. One adult and one child
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were randomly selected from each family, and the sample adult core and the sample child
core questionnaires were used to collect information respectively. The supplemental
questions included topics such as Healthy People objectives, cancer screening,
complementary and alternative medicine, children’s mental health, and healthcare
utilization (CDC, 2018). The 2015 National Health Interview Survey contained data for
41,493 households, containing 103,789 persons in 42,288 families. The number of
sample children is 12,291, and the number of sample adults is 33,672 (National Center
for Health Statistics [NCHS], NHIS, 2015).
The sample for this study consisted of women who were between the ages of 21
and 65. Women who had a hysterectomy or a history of cervical cancer were excluded.
The outcome variables were cervical cancer screening adherence, physician
recommendation, and adherence to physician recommendation. Cervical cancer
screening adherence was defined as having had at least one Pap test during the last 3
years, or for those 30-65 years of age by having had a Pap test and HPV test during the
last 5 years. Screening adherence was assessed by the following question: “When did
you have your most recent pap test?” “Did you have an HPV test with your most recent
pap?”
Demographic, acculturation, access to care and utilization, chronic conditions,
and health behaviors and knowledge variables were chosen based on existing literature
and explored as predictors for Pap test adherence. Demographic variables included age,
race/ethnicity, marital status, education level, and employment status. Marital status
included the following categories: married, widowed, separated, divorced, and never
married. Women who reported themselves as widowed, separated, or divorced were
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considered to be previously married in this study. Previously married and never married
women were then combined to create a variable for unmarried women.
Acculturation was assessed using the geographic region of birth, English
proficiency, and period of U.S. residence variables. Access to care variables included
insurance type, office visits in past 12 months, and usual source of care. A chronic
condition variable combined who had hypertension, high cholesterol, congestive heart
failure, heart disease, emphysema, chronic obstructive pulmonary disease, asthma,
cancer, or diabetes. Health behaviors and knowledge included BMI level, ever heard of
HPV, ever received HPV vaccine, age when first child born, doctor recommended Pap
test, birth control use, alcohol drinking status, smoking status, flu shot, risk perception of
breast cancer, and reported health status.
This study was reviewed by the Florida International University Office of
Research Integrity, and it was determined to be non human subjects research due to the
use of publically available de-identified data. Therefore, it did not require further
submission and approval of the FIU Institutional Review Board.

Inclusion and exclusion criteria
Sex: This was a categorical variable defined as 1) male and 2) female. Males
were excluded from this study.
Age: This was a continuous variable and was recoded into categories of 21 to 29
years, 30 to 39 years, 40 to 49 years, and 50 to 65 years based on previous literature
(Watson et al., 2017). Respondents less than 21 years and older than 65 years were
excluded from this study based on current screening guidelines (USPSTF, 2016).

35

Hysterectomy: Respondents who answered yes to the question “Have you had a
hysterectomy?” were excluded from this study based on current screening guidelines
(USPSTF, 2016).
Cervical cancer: Respondents who said they were told by a doctor or health
professional that they had cervical cancer were excluded to ensure they underwent
screening rather than surveillance (Hanske et al., 2016; Politi et al., 2008).
Ever had a Pap smear/test: Respondents who answered the question “Have you
ever had a Pap smear or Pap test?” were included in this study.
Among the 33,672 sample adults, 22,003 adults were excluded. Exclusion criteria
included being male (n=15,071), being younger than 21 years or older than 65 years old
(n=5,119), having had a hysterectomy (n=1,734), and history of cervical cancer (n=79).
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Figure 2: Inclusion Criteria, Exclusion Criteria, and Study Aims
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Outcome and predictor variables
Cervical cancer screening adherence: The questions for “when did you have your
most recent Pap test” were combined to determine whether they had their last Pap test in
the last 3 years, in the last 3 to 5 years, or more than 5 years ago. Respondents who
answered that they had their last Pap test in the last 3 years, or that they had their last Pap
test in the last 3 to 5 years AND answered yes to “did you have an HPV test with your
most recent Pap” were considered adherent to cervical cancer screening based on the
2012 U.S. Preventive Services Task Force recommendations (USPSTF, 2016).
Race/Ethnicity: This was a categorical variable defined as 1) Hispanic, 2) nonHispanic white, 3) non-Hispanic black, 4) Asian, and 5) all other race groups (Watson et
al., 2017).
Marital status: This was a categorical variable defined as 1) separated, 2)
divorced, 3) married, 4) single/never married, and 5) widowed. Separated and widowed
were recoded into one category.
Education level: The highest level of school completed was recoded as less than
high school, high school graduate or GED, some college or associate degree, and college
graduate (Watson et al., 2017; White et al., 2017).
Employment status: Respondents were asked if they worked for pay at any time
in the last calendar year with 1) yes and 2) no as the categories.
Geographic region of birth: This was a categorical variable to determine
birthplace. It was recoded into fewer categories: United States, Mexico/Central
America/Caribbean/South America, Europe/Russia, Africa, Middle East/Asia, and
elsewhere.
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English proficiency: Respondents were asked how well they speak English, and
the categories were recoded into very well/well and not well/not at all.
Period of U.S. residence: This was a categorical variable, which was recoded as
having been born in the United States, living in the United States for 10 years or more ,
and living in the United States for fewer than 10 years (Watson et al., 2017; White et al.,
2017).
Health care coverage: This was a categorical variable defined as 1) private, 2)
Medicaid and other public, 3) other coverage, and 4) uninsured (Watson et al., 2017).
Outpatient clinic visits in past 12 months: Total number of office visits in the past
12 months were recoded as none, one, two to three, and four or more.
Usual source of care: The questions “Is there a place that you usually go to when
you are sick or need advice about your health” and “what kind of place is it” were
combined to create two categories: Has usual source of care and none/hospital
emergency department (Watson et al., 2017; White et al., 2017).
Chronic conditions: This variable combined respondents who had ever been told
that they have hypertension, high cholesterol, congestive heart failure, heart disease,
emphysema, chronic obstructive pulmonary disease, asthma, cancer, or diabetes.
Body mass index (BMI): This was a continuous variable, which was recoded into
categories based on CDC guidelines: less than 18.5 (underweight), 18.5-24.9 (normal),
25-29.9 (overweight), 30 or greater (obese) (CDC, 2017b). The equation for BMI is as
follows: BMI = [Weight (kg) / [Height (m) squared]].
Ever heard of HPV: This was a categorical variable defined as 1) yes and 2) no.
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Ever received HPV shot/vaccine: This was a categorical variable defined as 1)
yes and 2) no.
Age when first child born: The questions “have you ever given birth to a live
born infant” and “how old were you when your child was born” were combined to create
the following categories: Never gave birth, less than 21 years, 21 to 29 years, and 30
years or older.
Physician recommendation: Respondents were asked whether a doctor or other
health professional recommended that they have a Pap test or Pap and HPV test in the
past 12 months, with categories of 1) yes, 2) no, and 3) did not see a doctor in the last 12
months.
Birth control: This was a categorical variable in which respondents answered yes
or no to the question “Are you currently taking birth control pills, birth control implants,
birth control shots, or have a birth control patch?”
Alcohol drinking status: This was a categorical variable, which was recoded as
lifetime abstainer, former drinker, and current drinker. A lifetime abstainers was defined
as consuming fewer than 12 drinks in a lifetime.
Smoking status: This was a categorical variable, which was recoded as never
smoker, former smoker, and current smoker.
Flu shot in past 12 months: This was a categorical variable defined as 1) yes and
2) no.
Risk perception of breast cancer: Respondents were asked “Compared to the
average women your age, would you say that you are more likely to get breast cancer,
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less likely, or about as likely?” The categories were recoded into more likely and less
likely/about as likely.
Reported health status: This was a categorical variable defined as 1) excellent, 2)
very good, 3) good, 4) fair, and 5) poor. Excellent and very good were recoded into the
same category, and fair and poor were recoded into the same category.

Data management and preparation
The public use files were downloaded from the Centers for Disease Control,
National Center for Health Statistics (NCHS) website
(https://www.cdc.gov/nchs/nhis/nhis_2015_data_release.htm). The 2015 Person, Sample
Adult, and Cancer files were merged together to create one dataset.

Statistical analysis
Descriptive analyses were first performed to describe the sample by the selected
variables for demographics, acculturation, access to care and utilization, chronic
conditions, and health behaviors and knowledge. The descriptive analyses included the
total number in the sample, the percent of the sample that it represented, screening
adherence percentages, and crude odds ratio with corresponding 95% confidence interval.
Multiple logistic regression models were used to examine the relationship first
between selected variables and the outcomes of interest (cervical cancer screening
adherence and physician recommendation), and then analysis was performed by race to
determine significant predictors. Backward elimination and stepwise procedures were
used for the selection of variables into the model. Multicollinearity was tested for to
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ensure predictors were not highly correlated. SAS 7.12 was used to perform the analysis.
All analyses included statistical weights to account for the complex survey design,
oversampling, post-stratification, and survey nonresponse. Weight, stratum, and cluster
variables were used to specify the sample design. SURVEY procedures and statements
were used to allow for correct estimation from a complex sample.

Missing
Missing data were coded as “.”. Refused, not ascertained, and don’t know
responses to survey questions were treated as missing data. Missing data were not
included in this study. The percentage of missing data for each variable was assessed.
Among the 11,669 eligible women, 1,002 (8.6%) women were coded as “refused”
(n=42), “not ascertained” (n=934), or “don’t know” (n=26) for the question “Have you
ever had a Pap smear or Pap test”. “Not ascertained” was used for partially completed
interviews where the participant discontinued the interview. The non-respondents were
not included in this study, as supported by other studies using the National Health
Interview Survey (Blackwell & Clarke, 2016; Blackwell & Clarke, 2018; Clarke, Nahin,
Barnes, & Stussman, 2016; Nahin, Barnes, & Stussman, 2016; Ward, Dahlhamer,
Galinsky, & Joestl, 2014). The respondents compared to non-respondents were similar
when analyzed by age, race/ethnicity, marital status, education level, and employment
status, and determined to be randomly missing. The final sample size was 10,667
women.
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Weighting
Each person in the NHIS sample has a known non-zero probability of selection,
which is reflected in sample weights in order to provide unbiased national estimates. The
base weights are adjusted for non-response and post-stratification to create final sampling
weights.
Beginning with the 2010 National Health Interview Survey, the National Center
for Health Statistics added a nonresponse adjustment for the sample adult weight. The
sample adult weight includes design, ratio, non-response, and poststratification
adjustments for sample adults. National estimates of all sample adult variables can be
made using these weights (NCHS, NHIS, 2015).
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CHAPTER IV.
MANUSCRIPT 1
Predictors of cervical cancer screening among a nationally representative sample of
women in the United States using current screening guidelines: 2015 National
Health Interview Survey

Abstract
Background: Cervical cancer is one of the most preventable diseases if diagnosed early,
but adherence to cervical cancer screening guidelines remains suboptimal. The objective
of this study was to identify demographic, acculturation, access to health care and health
behavior and knowledge factors associated with adherence to the current cervical cancer
screening guidelines, and to determine if these factors differed by race/ethnicity.
Methods: The 2015 National Health Interview Survey data were used to analyze cervical
cancer screening adherence behavior in a sample of 10,667 women. Demographic,
acculturation, access to care and utilization, chronic condition, and health behavior and
knowledge variables were analyzed using logistic regression for the entire group and then
stratified by race. The outcome of cervical cancer screening adherence was developed
based on current guidelines of having a Pap test in the last three years, or co-testing with
a Pap test and HPV test in the last five years. Results: Among these women, 81.7%
(95% CI 80.7-82.7%) adhered to cervical cancer screening. Screening adherence
declined with increasing age after the age of 39 years. Women who were never married
(adjusted odds ratio [aOR] 0.67, CI 0.56-0.79) or current smokers (aOR 0.70, CI 0.590.84) had lower odds to adhere to cervical cancer screening guidelines. Women with a
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college degree had greater odds to adhere to cervical cancer screening guidelines (aOR
1.38, CI 1.14-1.67). Positive health behaviors indicative of visiting a doctor were
significantly associated with adhering to cervical cancer screening guidelines.
Conclusion: Enhanced education about the importance of cervical cancer screening and
targeted interventions are needed for women aged under 30 and over 40 years, unmarried,
unemployed, uninsured women, women with less education, women with no usual source
of care, and current smokers.

Background
Previously one of the most common cancers among women in the United States,
cervical cancer now ranks as the 21st most common types of cancer (NCI, n.d.). In the
United States from 2009 to 2013, the incidence rate of cervical cancer was 7.5 per
100,000 women per year, and the mortality rate was 2.3 deaths per 100,000 women. The
risk that a woman will develop cervical cancer during her lifetime is 0.6 percent (NCI,
n.d.). Hispanic women had the highest incidence of cervical cancer, followed by nonHispanic black, white, American Indian/Alaska Native, and Asian/Pacific Islander
women. Non-Hispanic black women had the highest mortality rate, followed by
Hispanic, Asian/Pacific Islander, non-Hispanic white, and American Indian/Alaska
Native women (CDC, 2015).
Cervical cancer is highly preventable when screening and follow-up
recommendations are adhered to (CDC, 2015). If cervical cancer is diagnosed at an early
stage, it is treatable and associated with long survival (CDC, 2015). The five-year
observed survival rate decreases as the disease progresses. The five-year survival rate is
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93% at stage 0, 93% at stage IA, 80% at stage IB, 63% at stage IIA, 58% at IIB, 35% at
stage IIIA, 32% at stage IIIB, 16% at IVA, and 15% at stage IVB (ACS, 2016). Cervical
cancer is a slow-growing cancer, making it one of the most preventable cancers (NCCC,
2016).
Secondary prevention through cervical cancer screening identifies cervical
abnormalities. Cervical cancer deaths have decreased by 50% over the last 40 years due
to an increase in Pap test utilization (ACS, 2018). However, from 2008 to 2010, cervical
cancer screening rates declined slightly (Brown et al., 2014). According to the U.S.
Preventive Task Force, a Pap test is recommended for women between the ages of 21 and
65 years of age who have not had a hysterectomy. Recommendations for frequency of
cervical cancer screening have changed over the years. Currently, a Pap test is
recommended every three years. Cervical cancer screening is only recommended every
five years if there is co-testing with the HPV test. These recommendations do not apply
to women with a diagnosis of a high-grade precancerous cervical lesion or cervical
cancer, women with in utero exposure to diethylstilbestrol, women who are HIV infected,
or women who are otherwise immunocompromised (USPSTF, 2016).
Many studies on cervical cancer screening focus on specific geographic regions or
racial/ethnic groups. While the findings of previous studies have been consistent on the
association of demographic factors and cervical cancer screening, there are insufficient
results on chronic diseases. In addition, trends for some characteristics will vary over the
years and may indicate different populations for further study. Current analysis on
robust, national data is warranted to identify or confirm predictors and to explore
populations in need of interventions for the prevention of cervical cancer. In 2012, HPV
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and Pap co-testing for women over the age of 30 became a part of the cervical cancer
screening guidelines. There are two published articles which examined Pap test
adherence by sociodemographic characteristics and health care access using NHIS 2015
data. One study examined Pap test within three years and co-testing within three years
separately, while the other study combined both options together (White et al., 2017;
Watson et al., 2017). This study adds to current literature by taking current screening
guidelines into account when determining the characteristics of who gets screened. The
characteristics examined will go beyond demographic and health care access to also
assess the role of acculturation, chronic conditions, and health behavior and knowledge
on screening. The objective of this study was to identify demographic, acculturation,
access to health care and health behavior and knowledge factors associated with
adherence to the current cervical cancer screening guidelines and to determine if these
factors differed by race/ethnicity. Variables were chosen based on existing literature and
considered as predisposing, reinforcing, or enabling factors using the
PRECEDE/PROCEED model (Hatcher et al., 2011; Ji et al., 2010).

Methods
The data source for this study was the 2015 National Health Interview Survey
(NHIS) (National Center for Health Statistics, CDC, 2017). The NHIS is a crosssectional household interview survey with a multistage area probability design that
allowed for representative sampling of household and non-institutional group quarters.
The sampling plan was a sample of clusters of addresses in primary sampling units,
which consisted of a county, small group of contiguous counties, or a metropolitan
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statistical area (CDC, 2018). The 2015 Person, Sample Adult, and Cancer files were
merged together.
The sample for this study consisted of women who were between the ages of 21
and 65. Women who had a hysterectomy or a history of cervical cancer were excluded.
The outcome variable was cervical cancer screening adherence. Cervical cancer
screening adherence was defined by having had at least one Pap test during the last 3
years, or for those 30-65 by having had a Pap test and HPV test during the last 5 years.
Screening adherence was assessed by the following question: “When did you have your
most recent pap test?” “Did you have an HPV test with your most recent pap?”
Demographic, acculturation, access to care and utilization, chronic conditions,
and health behaviors and knowledge variables were explored as predictors for Pap test
adherence. Demographic variables included age, race/ethnicity, marital status, education
level, and employment status. Acculturation was assessed using the geographic region of
birth, English proficiency, and period of U.S. residence variables. Access to care
variables included insurance type, office visits in past 12 months, and usual source of
care. A chronic condition variable combined hypertension, high cholesterol, congestive
heart failure, heart disease, emphysema, chronic obstructive pulmonary disease, asthma,
cancer, or diabetes. Health behaviors and knowledge included BMI level, ever heard of
HPV, ever received HPV vaccine, age when first child born, doctor recommended pap
test, birth control use, alcohol drinking status, smoking status, flu shot, risk perception of
breast cancer, and reported health status.
A multiple logistic regression model was used to examine the relationship first
between selected variables and cervical cancer screening adherence, and then analysis
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was performed by race to determine significant predictors. Backward elimination and
stepwise procedures were used for the selection of variables into the model.
Multicollinearity was tested to ensure predictors were not highly correlated. SAS 7.12
was used to perform the analysis. All analyses included statistical weights to account for
the complex survey design, oversampling, post-stratification, and survey nonresponse.
Weight, stratum, and cluster variables were used to specify the sample design. SAS Proc
SURVEY and its statements were used to allow for correct estimation from a complex
sample. This study was determined to be non human subjects research due to the use of
publically available de-identified data.

Results
The sample consisted of 10,667 women between the ages of 21 and 65 without a
hysterectomy or history of cancer, representing 75,830,736 women in the United States.
Of these, 81.7% were adherent to cervical cancer screening. Table 1 shows the
distribution of characteristics among the sample and the crude odds of adherence for each
characteristic. Of all the age groups, women aged 21 to 29 years reported the lowest
cervical cancer screening adherence (76.0%). Cervical cancer screening adherence
among non-Hispanic black and non-Hispanic white women was higher (84.2% and
83.4%, respectively) than that among women belonging to Hispanic, Asian, and other
racial/ethnic groups (77.8%, 72.6%, and 73.1%, respectively). Cervical cancer screening
adherence was higher among women who were married (85.5%) as compared to other
marital statuses, and who were employed last year (84.5%). Cervical cancer screening
adherence increased with higher education.
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Cervical cancer screening adherence was higher among women who spoke
English well (82.5%) as compared to not well (69.6%). Only 65.1% of women living in
the United States for fewer than 10 years reported cervical cancer screening adherence as
compared to 78.3% of women in the United States for 10 or more years, and 83.3% of
women born in the United States.
Cervical cancer screening adherence was higher among women who had private
health insurance (85.6%). Screening adherence increased as the number of outpatient
clinic visits in the past 12 months increased, with four or more office visits in the prior
year being the highest (88.1%). Women who did not have a usual source of care had a
lower percentage of screening adherence (64.9%) as compared to women who did have a
usual source of care (84.4%). Women who had at least one chronic condition (83.4%)
had higher screening adherence as compared to women with no chronic conditions
(80.3%). Women with a BMI of 25-29.9 (overweight) had the highest percentage of
screening adherence (82.5%) as compared to all other BMI categories. Women with
knowledge of HPV (85.9%) and receipt of the HPV vaccine (89.5%) had higher rates of
cervical cancer screening adherence. Screening adherence increased with increasing age
of when the first child was born. Women who did not have physician recommendation
for a Pap test had lower screening adherence (78.5%) than those who did have physician
recommendation (89.3%). Among women using birth control pills, implants or shots,
91.3% adhered to screening guidelines. Current alcohol drinkers (85.5%) and former
smokers (86.0%) had the highest rates of screening adherence as compared to those who
abstained from alcohol (71.5%) or were never smokers (82.1%). Women who had a flu
shot in the past 12 months had a higher rate of screening adherence (88.5%). Women

51

who perceived themselves to be less likely to get breast cancer as compared to average
women had a lower percentage of adherence (81.5%). Screening adherence was higher
among women who reported excellent or good health status (82.4%) than among women
who reported fair or poor health status (75.3%).
We performed a multivariable analysis to calculate the odds ratios for cervical
cancer screening adherence, adjusting for other variables (Table 1.2). Non-Hispanic
black women (aOR 2.26, 95% CI 1.83-2.80) and Hispanic women (aOR 1.47, 95% CI
1.16-1.86) had higher odds of cervical cancer screening adherence as compared to nonHispanic white women. Women between the ages of 30 and 39 had the highest
likelihood of adhering to cervical cancer screening (aOR 1.59, 95% CI 1.30-1.94).
Screening rates decreased after 39 years of age but were still higher than those among the
21 to 29 year age group. Compared with the youngest age group, those who were 30 to
39 years of age had the highest odds to adhere to cervical cancer screening if nonHispanic white (aOR 1.71, 95% CI 1.16-2.53) or Hispanic (aOR 1.50, 95% CI 1.01-2.23)
but not for non-Hispanic black women (aOR 1.33, 95% CI 0.70-2.50). Women who were
never married were least likely to adhere to cervical cancer screening as compared to
other marital status (aOR 0.67, 95% CI 0.56-0.79). Among non-Hispanic white and
Hispanic women, never married compared to married women had lower odds of getting
screened (aOR 0.48, 95% CI 0.35-0.68; and aOR 0.60, 95% CI 0.41-0.87, respectively),
but there was no difference among non-Hispanic black women (aOR 0.95, 95% CI 0.531.72). Higher odds of cervical cancer screening adherence were associated with being a
college graduate (aOR 1.38, 95% CI 1.14-1.67) compared with other education levels,
and with having worked last year compared with not having worked last year.
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Graduation from college and having worked last year were significantly associated with
screening among non-Hispanic white and black women but not for Hispanic women.
Lower odds of screening adherence were associated with being born in the Middle East
or Asia (aOR 0.62, 95% CI 0.38-0.99), being uninsured (aOR 0.72, 95% CI 0.59-0.88),
having no office visits in the past 12 months (AOR 0.54, 95% CI 0.45-0.66), and having
no usual source of care or using a hospital emergency department (aOR 0.68, 95% CI
0.57-0.81). Non-Hispanic white (aOR 0.66, 95% CI 0.45-0.97) and Hispanic (aOR 0.59,
95% CI 0.37-0.94) women who were uninsured had lower odds to adhere to cervical
cancer screening but were not significantly different than non-Hispanic black women
(aOR 0.55, 95% CI 0.28-1.12). Not having a usual source of care was a significant factor
only among non-Hispanic white women (aOR 0.64, 95% CI 0.47, 0.87). Women with no
office visits in the past 12 months were less likely to adhere to cervical cancer screening
among non-Hispanic white (aOR 0.52, 95% CI 0.34, 0.79), non-Hispanic black (aOR
0.50, 95% CI 0.26-0.96), and Hispanic women (aOR 0.46, 95% CI 0.30-0.71).
Higher odds of cervical cancer screening adherence were associated with having
heard of HPV, having received an HPV shot, being over 30 years old when the first child
was born, physician recommendation for a Pap test, birth control use, and having
received a flu shot in the past 12 months. Non-Hispanic white (aOR 0.56, 95% CI 0.350.88) and Hispanic (aOR 0.43, 95% CI 0.25-0.76) women who had never received an
HPV shot were less likely to adhere to cervical cancer screening but were not significant
among non-Hispanic black women (aOR 0.88, 95% CI 0.46-1.70). Women who
currently drank alcohol compared with never drinkers had greater odds (aOR 1.50, 95%
CI 1.27-1.76) to adhere to cervical cancer screening recommendations; whereas current
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smokers had lower odds (aOR 0.70, 95% CI 0.59-0.84) than never smokers. Women
who had not heard of HPV, who had never given birth, with no physician
recommendation for a Pap test, with no birth control use, and with no flu shot in the last
12 months had lower odds to adhere to cervical cancer screening among non-Hispanic
white, non-Hispanic black, and Hispanic women. Alcohol drinking and smoking status
and reported health status were only significant among non-Hispanic white women.
Lower odds of screening adherence were associated with having reported fair or poor
health status (aOR 0.72, 95% CI 0.59-0.88).

Discussion
Recognizing cervical cancer as a highly preventable disease as well as needs for
updated national data to determine which groups to target, we assessed 2015 NHIS data
to identify predictors of cervical cancer screening as well as racial disparities. In
addition, we used the current guidelines of either having a Pap test in the last 3 years or
having a Pap test and HPV test in the last 5 years as the outcome. Among women aged
21 to 65 years with no hysterectomy and no history of cervical cancer, 81.7% were
adherent to cervical cancer screening guidelines. This translates into 61,922,182 women.
However, no group of women examined in this study reached the Healthy People 2020
objective of 93% of women screened. Women currently taking birth control pills,
implants, or shots (91.3%) are the closest group to achieving this target. We found a
number of factors affected the screening behavior among women, which included
race/ethnicity, age, marital status, education, work status, insurance, physician office
visits, usual source of care, knowledge of HPV, HPV vaccination, age when first child
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born, doctor recommendation, birth control use, alcohol and smoking status, flu shot in
the last 12 months, and reported health status.
Racial disparities are important to analyze to understand where additional
resources are needed. Stratified by race, differences in associated characteristics with
adherence were evident. Overall, non-Hispanic black women were more than twice as
likely as non-Hispanic white women to adhere to cervical cancer screening. With nonHispanic black women having higher incidence and mortality rates for cervical cancer as
compared to non-Hispanic white women, other factors, such as follow-up to abnormal
pap test results, need to be studied to better understand this disparity. Understanding the
significant predictors by race is imperative in providing the appropriate education and
interventions to targeted groups.
In addition, recent studies have shown being non-Hispanic white reduced the
likelihood of cervical cancer screening (Miles-Richardson et al., 2017). There are racial
and ethnic differences in the association of these demographic factors with cervical
cancer screening. Hispanic and other race women were more likely (11.1% and 14.7%,
respectively) to never have a Pap test than non-Hispanic white women (5.0%) or black
women (5.8%) (Chen et al., 2012). Among non-Hispanic white and black women,
insurance was associated with increased likelihood of receipt of a Pap smear (Hirth et al.,
2016).
Our study found that women who were born in the Middle East or Asia were less
likely to adhere to cervical cancer screening guidelines. Studies have shown that foreign
born women are less likely to adhere to Pap testing recommendations compared with
women born in the United States. There are further differences based on duration of time
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spent in the United States and by birthplace (Tsui, Saraiya, Thompson, Dey, &
Richardson, 2007). Cultural beliefs about the etiology of cervical cancer affect Pap
testing among immigrant women (McMullin et al., 2005).
Our findings on the demographic variables and the percentage of adherence
concurred with past research (White et al., 2017; Watson et al., 2017).
Sociodemographic factors have been shown to be predictors of cervical cancer screening
(Miles-Richardson et al., 2017). According to the 2000 National Health Interview
Survey, age, race/ethnicity, education, health insurance, and a usual source of care were
associated with cervical cancer screening (Meissner et al., 2009). With the median age of
diagnosis of cervical cancer being 49 years, it is interesting to note our finding that the
likelihood of screening declines after the age of 39. This indicates a need for enhancing
education to women over the age of 40 and to emphasize continued screening. While it is
crucial to start screening at the age of 21, it is important to adhere to current screening
guidelines even as age increases to find any cervical cell changes at an early stage. NonHispanic white women and Hispanic women between the ages of 30 and 39 were most
likely to get screened for cervical cancer as compared to other age groups, whereas age
was not significant for non-Hispanic black women. This may be a result of cultural
beliefs and the age at which such services are deemed to be necessary. In addition, they
also may have been screened as part of obstetric care or when obtaining birth control.
Women who did not work the previous year were 35% less likely to have adhered to
cervical cancer screening guidelines. Women who did not work the previous year may
have fewer financial resources for screening such as insurance and transportation, which
may have hindered health seeking behaviors. Women without insurance were 28% less

56

likely to adhere to cervical cancer screening guidelines, similar to women who did not
work the previous year. Women who did not work the previous year were significantly
associated with nonadherence among non-Hispanic women but not among Hispanic
women. Also, lack of insurance was significantly associated with nonadherence among
non-Hispanic white women and Hispanic women but not among non-Hispanic black
women.
Low family income, low educational level, and being unmarried have been shown
to be associated with lower rates of Pap testing (Hewitt et al., 2004). In our study,
unmarried categories were differentiated as widowed or separated, divorced, and never
married. Women who were never married were the least likely to adhere to cervical
cancer screening as compared to the other unmarried categories. One theory is that some
women in the never married category may not currently be sexually active, and may
erroneously believe they are not at risk for cervical cancer. A recent study found single,
separated/divorced, and widowed women are more likely to be diagnosed with cervical
cancer at an advanced stage as compared to married women (Ibrahimi & Pinheiro, 2017).
This further emphasizes the importance of cervical cancer screening for unmarried
women. Non-Hispanic white women and Hispanic women who were never married were
least likely to be screened, but this was not a significant predictor for non-Hispanic black
women.
Systematic reviews have shown a positive association between education and
cervical cancer screening (Damiani et al., 2015), as well as between health literacy and
cervical cancer (Kim & Han, 2016). Educational attainment has been shown to have a
significant correlation with knowledge of cervical cancer risk factors (Akinlotan et al.,
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2017). Many studies regarding education, knowledge, and perceptions focus on specific
ethnic groups. The most common reason for lack of regular Pap testing is the belief that
it is not necessary if no symptoms are present (Juon et al., 2003). College graduates were
38% more likely to adhere to cervical cancer screening guidelines as compared to a high
school graduate. Thus, cervical cancer screening adherence improves with increasing
education even past a high school degree. Having a college degree was significantly
associated with screening adherence among non-Hispanic women but not among
Hispanic women.
Research on the association of chronic conditions and cancer screening has shown
varied results. Some studies have found that chronic conditions such as diabetes are a
barrier to cancer screening, while other studies have found that chronic diseases increase
the likelihood of cancer screening adherence (Brown et al., 2013; Guo et al., 2015; Liu et
al., 2014). Some have theorized that the presence of a chronic condition indicates more
physician visits, which may increase the likelihood of pursuing other preventive health
measures. Here, we found that having a chronic condition such as diabetes had a higher
association with cervical cancer screening adherence than not having a chronic condition.
One could speculate that having a chronic condition may mean more doctors’ visits,
which may provide more opportunities for recommending preventive screenings.
Physician recommendation for a Pap test is significantly associated with adherence to
cervical cancer screening. Women who did not have a Pap test recommended were 46%
less likely to adhere to screening guidelines. Even specialists should stay up-to-date on
preventive care guidelines to ensure they can provide guidance to their patients, even if
the visit is for other reasons.
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This study supports the importance of health behaviors and knowledge in
adhering to cervical cancer screening guidelines. Women who had heard of HPV and
who had an HPV vaccine were more likely to get cervical cancer screening. The number
of office visits in the last 12 months had a positive association with cervical cancer
screening. Doctor recommendation also influenced more women to get cervical cancer
screening. Women who use birth control or have had a flu shot in the last 12 months
were more likely to get screened for cervical cancer. All of these findings show that
visiting a doctor improves the likelihood of cervical cancer screening. In addition,
behaviors indicative of preventive health may make women more likely to pursue cancer
screening as well.
Women who are current drinkers were more likely to adhere to cervical cancer
screening as compared to lifetime abstainers; whereas women who are current smokers
were less likely to adhere to cervical cancer screening as compared to never smokers. A
previous cross-sectional study using the Behavioral Risk Factor Surveillance System also
found that the odds of current smokers having had a Pap test in the last 3 years was 0.70
as compared to never smokers (MacLaughlan, Lachance, & Gjelsvik, 2011). With
smoking being a risk factor for cervical cancer, current smokers should be targeted for
interventions to increase their adherence to pap testing and consequently diagnosis at an
earlier stage of the disease.
The limitations of this study included self-reported data, which may not
accurately capture cervical cancer screening adherence as a result of recall bias, social
desirability, and over-reporting of Pap test utilization. Women may also erroneously
believe their pelvic exam included a Pap test.
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Enhanced education about the importance of cervical cancer screening and
targeted interventions are needed for women aged under 30 and over 40 years, unmarried,
unemployed, uninsured women, women with less education, women with no usual source
of care, and current smokers.
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Table 1.1: Percentage of women with cervical cancer screening adherence by selected characteristics - National Health
Interview Survey, United States, 2015 (N=10,667)
Variables

Total

Total
Weighted

10,667
75,830,736

Sample %

% Adherent
(weighted)

Crude OR (95% CI)

81.7

Demographics
Age
21-29 years
30-39 years
40-49 years
50-65 years

2286
2745
2255
3381

21.4
25.7
21.1
31.7

76.0
86.7
83.2
80.9

1.00
2.06*** (1.69, 2.51)
1.56*** (1.26, 1.93)
1.34** (1.12, 1.59)

Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Asian
Other

6068
2140
1601
704
154

56.9
20.1
15.0
6.6
1.4

83.4
77.8
84.2
72.6
73.1

1.00
0.70*** (0.59, 0.82)
1.06 (0.88, 1.28)
0.53*** (0.42, 0.67)
0.54* (0.33, 0.89)

Marital Status
Married
Widowed or Separated
Divorced
Never married

4936
812
1661
3234

46.4
7.6
15.6
30.4

85.5
79.0
81.3
74.5

1.00
0.64** (0.49, 0.84)
0.74** (0.60, 0.91)
0.50*** (0.43, 0.58)
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Highest level of school completed
Less than high school
High school graduate or GED
Some college or associate degree
College graduate

1238
2184
3496
3720

11.6
20.5
32.9
35.0

69.3
75.8
81.6
88.2

0.72*** (0.58, 0.90)
1.00
1.42*** (1.17, 1.72)
2.39*** (1.97, 2.90)

Employed last year
Yes
No

7865
2795

73.8
26.2

84.5
73.7

1.00
0.51*** (0.45, 0.59)

Acculturation
Geographic region of birth
United States
Mexico, C. America, Caribbean, S. America
Europe, Russia
Africa
Middle East, Asia
Elsewhere

8348
1392
182
113
568
56

78.3
13.1
1.7
1.1
5.3
0.5

83.3
77.9
78.0
70.0
71.1
76.4

1.00
0.70*** (0.58, 0.85)
0.71 (0.46, 1.09)
0.47** (0.28, 0.77)
0.49*** (0.39, 0.63)
0.65 (0.28, 1.48)

How well is English spoken
Very well, well
Not well, not at all

9838
829

92.2
7.8

82.5
69.6

1.00
0.48*** (0.40, 0.59)

Period of U.S. Residence
U.S. born
In U.S. ≥ 10 years
In U.S. < 10 years

8348
1818
475

78.5
17.1
4.5

83.3
78.3
65.1

1.00
0.72*** (0.61, 0.85)
0.37*** (0.30, 0.47)

64

Access to Care and Utilization
Health care coverage
Private
Medicaid and other public
Other coverage
Uninsured

6751
1859
478
1340

64.7
17.8
4.6
12.9

85.6
78.2
84.0
64.0

1.00
0.60*** (0.51, 0.71)
0.89 (0.64, 1.23)
0.30*** (0.25, 0.36)

Outpatient clinic visits - past 12 months
None
1
2-3
4+

1587
1838
3018
4209

14.9
17.3
28.3
39.5

56.5
80.0
86.1
88.1

0.32*** (0.26, 0.40)
1.00
1.55*** (1.26, 1.92)
1.85*** (1.53, 2.24)

Usual source of care
Has usual source
None or hospital emergency department

9157
1441

86.4
13.6

84.4
64.9

1.00
0.34*** (0.29, 0.41)

Chronic Conditions
No
Yes

5735
4779

54.5
45.5

80.3
83.4

1.00
1.23** (1.07, 1.42)

Health Behaviors and Knowledge
Body Mass Index
<18.5
18.5-24.9
25-29.9
>=30

226
3913
2724
3666

2.1
37.2
25.9
34.8

69.4
81.9
82.5
81.5

0.50*** (0.34, 0.75)
1.00
1.05 (0.88, 1.24)
0.98 (0.83, 1.15)

Ever heard of HPV
Yes
No

7854
2552

75.5
24.5

85.9
69.0

1.00
0.35*** (0.31, 0.41)
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Ever received HPV shot/vaccine
Yes
No

1173
8972

11.6
88.4

89.5
80.8

1.00
0.50*** (0.38, 0.64)

Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

3189
2472
3644
1274

30.1
23.4
34.4
12.0

74.8
80.5
85.8
89.7

1.00
1.39*** (1.16, 1.65)
2.03*** (1.72, 2.38)
2.92*** (2.27, 3.75)

Doctor recommended pap test
Yes
No
Did not see a doctor in the past 12 months

5566
4392
479

53.3
42.1
4.6

89.3
78.5
54.7

1.00
0.44*** (0.38, 0.51)
0.15*** (0.11, 0.19)

Currently taking birth control pills,
implants, or shots
Yes
No

1877
8676

17.8
82.2

91.3
79.7

1.00
0.37*** (0.30, 0.47)

Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

2315
1278
7017

21.8
12.0
66.1

71.5
78.6
85.5

1.00
1.46*** (1.18, 1.82)
2.35*** (2.00, 2.75)

Smoking status
Never smoker
Former smoker
Current smoker

7222
1719
1713

67.8
16.1
16.1

82.1
86.0
74.9

1.00
1.34** (1.12, 1.60)
0.65*** (0.54, 0.78)
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Flu shot past 12 months
Yes
No

4310
6341

40.5
59.5

88.5
76.9

1.00
0.43*** (0.38, 0.50)

Risk of breast cancer compared to average
women
More likely
Less likely, about as likely

1178
8888

11.7
88.3

85.7
81.5

1.00
0.74** (0.59, 0.92)

Reported health status
Excellent, very good, or good
Fair or poor

9421
1245

88.3
11.7

82.4
75.3

1.00
0.65*** (0.54, 0.79)

*<0.05, **<0.01, ***<0.001
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Table 1.2: Adjusted odds ratios of cervical cancer screening adherence by race - National Health Interview Survey, United States, 2015
Variables

Overall

Non-Hispanic White

Non-Hispanic Black

Hispanic

8,898

4,582

1,219

1,501

Demographics
Age
21-29 years
30-39 years
40-49 years
50-65 years

1.00
1.59*** (1.30, 1.94)
1.24 (1.00, 1.54)
0.96 (0.78, 1.19)

1.00
1.71** (1.16, 2.53)
0.87 (0.59, 1.29)
0.80 (0.56, 1.14)

1.00
1.33 (0.70, 2.50)
1.11 (0.56, 2.22)
1.04 (0.52, 2.07)

1.00
1.50* (1.01, 2.23)
1.40 (0.87, 2.25)
1.26 (0.71, 2.23)

Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Asian
Other

1.00
1.47** (1.16, 1.86)
2.26*** (1.83, 2.80)
1.16 (0.75, 1.78)
1.11 (0.67, 1.84)

-

-

-

Marital Status
Married
Widowed or Separated
Divorced
Never married

1.00
0.90 (0.71, 1.15)
0.94 (0.77, 1.14)
0.67*** (0.56, 0.79)

1.00
0.91 (0.60, 1.38)
0.97 (0.68, 1.39)
0.48*** (0.35, 0.68)

1.00
0.90 (0.45, 1.81)
0.46 (0.21, 1.01)
0.95 (0.53, 1.72)

1.00
1.09 (0.54, 2.22)
1.58 (0.87, 2.89)
0.60** (0.41, 0.87)

Highest level of school completed
Less than high school
High school graduate or GED
Some college or associate degree
College graduate

1.04 (0.83, 1.29)
1.00
1.11 (0.94, 1.32)
1.38*** (1.14, 1.67)

0.82 (0.49, 1.37)
1.00
1.02 (0.73, 1.43)
1.61** (1.13, 2.30)

0.69 (0.40, 1.19)
1.00
1.58 (0.96, 2.63)
2.46** (1.34, 4.51)

0.75 (0.48, 1.16)
1.00
0.96 (0.64, 1.45)
1.33 (0.66, 2.66)

Total
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Work last year
Yes
No

1.00
0.65*** (0.56, 0.75)

1.00
0.64** (0.48, 0.84)

1.00
0.52** (0.33, 0.81)

1.00
0.74 (0.50, 1.10)

Acculturation
Geographic region of birth
United States
Mexico, Central America, Caribbean, South America
Europe, Russia
Africa
Middle East, Asia
Elsewhere

1.00
1.24 (0.94, 1.64)
0.72 (0.46, 1.14)
0.58 (0.31, 1.06)
0.62* (0.38, 0.99)
1.27 (0.55, 2.93)

1.00
0.56* (0.34, 0.92)
0.76 (0.12, 4.89)
0.47 (0.17, 1.35)
0.80 (0.23, 2.78)

1.00
0.67 (0.29, 1.56)
3.02 (0.19, 47.01)
0.87 (0.37, 2.07)
0.21 (0.03, 1.77)

1.00
1.22 (0.79, 1.89)
0.24* (0.06, 0.95)
-

Access to Care and Utilization
Health care coverage
Private
Medicaid and other public
Other coverage
Uninsured

1.00
0.94 (0.77, 1.14)
0.96 (0.71, 1.29)
0.72* (0.59, 0.88)

1.00
0.93 (0.65, 1.34)
1.40 (0.85, 2.31)
0.66* (0.45, 0.97)

1.00
0.85 (0.52, 1.42)
1.20 (0.55, 2.64)
0.55 (0.28, 1.12)

1.00
0.84 (0.54, 1.30)
1.24 (0.54, 2.83)
0.59* (0.37, 0.94)

Outpatient clinic visits - past 12 months
None
1
2-3
4+

0.54** (0.45, 0.66)
1.00
1.38*** (1.14, 1.67)
1.74*** (1.44, 2.09)

0.52** (0.34, 0.79)
1.00
1.41 (1.00, 1.99)
1.66** (1.21, 2.29)

0.50* (0.26, 0.96)
1.00
1.90 (0.96, 3.75)
1.75 (0.99, 3.09)

0.46*** (0.30, 0.71)
1.00
1.06 (0.67, 1.70)
1.62* (1.02, 2.58)

Usual source of care
Has usual source
None or hospital emergency department

1.00
0.68*** (0.57, 0.81)

1.00
0.64** (0.47, 0.87)

1.00
1.10 (0.59, 2.06)

1.00
0.98 (0.63, 1.53)
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Health Behaviors and Knowledge
Ever heard of HPV
Yes
No

1.00
0.56*** (0.49, 0.65)

1.00
0.58*** (0.44, 0.76)

1.00
0.40*** (0.26, 0.62)

1.00
0.54*** (0.38, 0.75)

Ever received HPV shot/vaccine
Yes
No

1.00
0.64*** (0.50, 0.83)

1.00
0.56* (0.35, 0.88)

1.00
0.88 (0.46, 1.70)

1.00
0.43** (0.25, 0.76)

Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

1.00
2.20*** (1.81, 2.67)
2.02*** (1.70, 2.40)
2.56*** (2.00, 3.34)

1.00
1.85** (1.29, 2.65)
1.61** (1.18, 2.20)
1.77** (1.16, 2.69)

1.00
2.94*** (1.73, 5.01)
1.83* (1.02, 3.27)
2.64* (1.05, 6.64)

1.00
3.54*** (2.17, 5.76)
3.76*** (2.46, 5.74)
5.21*** (2.23, 12.17)

Doctor recommended pap test
Yes
No
Did not see a doctor in the past 12 months

1.00
0.54*** (0.47, 0.61)
0.38*** (0.29, 0.49)

1.00
0.66*** (0.52, 0.84)
0.51* (0.29, 0.88)

1.00
0.42*** (0.27, 0.67)
0.27** (0.10, 0.72)

1.00
0.50*** (0.34, 0.72)
0.47* (0.24, 0.91)

Currently taking birth control pills, implants, or
shots
Yes
No

1.00
0.47*** (0.38, 0.59)

1.00
0.50*** (0.35, 0.70)

1.00
0.46* (0.23, 0.90)

1.00
0.67* (0.46, 0.97)

Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

1.00
1.10 (0.89, 1.37)
1.50* (1.27, 1.76)

1.00
1.00 (0.69, 1.46)
1.61** (1.16, 2.23)

1.00
1.12 (0.56, 2.26)
0.96 (0.59, 1.57)

1.00
1.00 (0.52, 1.90)
1.48 (0.99, 2.20)

Smoking status
Never smoker
Former smoker
Current smoker

1.00
1.00 (0.82, 1.211)
0.70* (0.59, 0.84)

1.00
1.00 (0.74, 1.34)
0.70* (0.51, 0.96)

1.00
1.97 (0.89, 4.35)
0.97 (0.54, 1.74)

1.00
0.85 (0.41, 1.75)
0.98 (0.59, 1.61)
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Flu shot past 12m
Yes
No

1.00
0.66*** (0.57, 0.76)

1.00
0.65*** (0.51, 0.84)

1.00
0.57** (0.38, 0.85)

1.00
0.65* (0.42, 0.99)

Reported health status
Excellent, very good, or good
Fair or poor

1.00
0.72** (0.59, 0.88)

1.00
0.67* (0.48, 0.96)

1.00
0.71 (0.37, 1.35)

1.00
1.35 (0.89, 2.07)

*<0.05, **<0.01, ***<0.001
1.

2.

There were 1,769 records that could not be used in the analysis due to missing values (24 for missing marital status, 29 for missing education, 7 for
missing work status, 8 for missing region of birth, 239 for missing insurance status, 15 for missing number of office visits, 69 for missing usual
source of care, 261 for missing HPV knowledge, 522 for receipt of HPV vaccine, 88 for missing maternal age, 230 for missing physician
recommendation, 114 for missing birth control use, 57 for missing alcohol use, 13 for missing smoking status, and 16 for missing flu shot).
The odds ratios were adjusted for all the factors.
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CHAPTER V.
MANUSCRIPT 2
Association of marital status with cervical cancer screening among women aged 21
to 65 years in the United States, 2015 National Health Interview Survey

Abstract
Background: Despite evidence that adherence to screening guidelines decreases
mortality, women are still dying from a preventable disease due to underutilization of
screening. Studies have found that unmarried women are more likely to have a delayedstage cervical cancer diagnosis as compared to married women, suggesting
underutilization of cervical cancer screening among unmarried women. The primary aim
of this study was to examine cervical cancer screening adherence in the United States
among unmarried women, including women who were divorced, separated, widowed, or
never married. Methods: The 2015 National Health Interview Survey data were used to
explore cervical cancer screening adherence behavior in 10,643 women between the ages
of 21 and 65 years. Cervical cancer screening adherence was defined as having a Pap test
in the last three years, or co-testing with a Pap test and HPV test in the last five years.
Previously married and never married women were combined to create a variable for a
sample of 5,707 unmarried women. Logistic regression was used, and demographics,
acculturation, access to care and utilization, chronic condition, and health behavior and
knowledge variables were studied by race. Results: Among unmarried women, 78.6% were
adherent. Women aged 30 to 39 years of age had the highest odds of screening adherence

(aOR 2.38, CI 1.71-3.31). Women who were not employed last year (aOR 0.48, CI 0.38-
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0.62), had no physician office visits (aOR 0.58, CI 0.40-0.85), did not have a usual source
of care (aOR 0.67, CI 0.50-0.89), had never heard of HPV (aOR 0.59, CI 0.46-0.76), had
never received an HPV shot (aOR 0.50, CI 0.34-0.75), were not currently taking birth
control pills (aOR 0.33, CI 0.23-0.47), did not get a flu shot in the past 12 months (aOR
0.62, CI 0.48-0.80), and perceived their risk of breast cancer as less likely or about as
likely as the average women (aOR 0.66, CI 0.47-0.92) had a lower odds of screening
adherence, regardless of race. Conclusion: Unmarried women had lower rates of
cervical cancer screening adherence as compared to married women. Targeted
interventions are needed to increase screening among unmarried women, particularly
those who are not employed and do not pursue preventive measures such as physician
office visits and flu shots.

Background
In 2015, there were approximately 257,524 women with cervical cancer in the
United States. In 2018, there are 13,240 estimated new cases of cervical cancer, which is
0.8% of all new cancer cases. There are 4,170 estimated deaths, which represents 0.7%
of all cancer deaths. Among women with cervical cancer, 66.2% survive five years after
being diagnosed (NCI, 2018).
The United States Preventive Services Task Force recommends cervical cancer
screening for women ages 21 to 65 years old. Appropriate screening methods are a
Papanicolaou (Pap) smear every 3 years or, for women 30 years of age or older, a Pap
smear and human papillomavirus (HPV) co-test every five years (USPSTF, 2016).
Despite evidence that adherence to screening guidelines decreases mortality, women are
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still developing invasive cervical cancer and dying from a rather preventable disease due
to underutilization of screening (Benard et al., 2014). Approximately 81% of United
States women are up-to-date on cervical cancer screening, which is short of the Healthy
People 2020 goal of 93% (Watson et al., 2017; ODPHP, 2018). Therefore, it continues to
be important to identify factors associated with cervical cancer screening adherence.
Marital status has been identified as a factor associated with cervical cancer
screening (Chen et al., 2012). Moreover, studies have found that being unmarried is a
predictor of delayed-stage cervical cancer diagnosis (Politi et al., 2008; Saghari et al.,
2015). This suggests underutilization of cervical cancer screening among unmarried
women, which can lead to a greater risk for adverse health outcomes. In 2016, there were
over 61 million unmarried adult women in the United States, which includes women who
were widowed, divorced, separated, or never married (Census Bureau, 2017). There is
limited evidence on the effect of marital status on cervical cancer screening adherence
among United States women. In addition, black and Hispanic women have the highest
age-adjusted mortality attributed to cervical cancer in the United States (Saghari et al.,
2015). The primary aim of this study was to examine cervical cancer screening
adherence in the United States among married and unmarried women, including women
who were divorced, separated, widowed, or never married. Unmarried women were also
stratified by race to better understand screening behaviors.

Methods
We used the 2015 National Health Interview Survey (NHIS) for this study
(National Center for Health Statistics, CDC, 2017). The NHIS is a cross-sectional
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household interview survey with a multistage area probability design that allows for
representative sampling of household and non-institutional group quarters. The sampling
plan was a sample of clusters of addresses in primary sampling units, which consist of a
county, small group of contiguous counties, or a metropolitan statistical area (CDC,
2018).
The NHIS questionnaire had core and supplemental questions. The core
questionnaire consisted of household, family, sample adult, and sample child
components. The supplemental questions included topics such as Healthy People
objectives, cancer screening, complementary and alternative medicine, children’s mental
health, and healthcare utilization (CDC, 2018). The 2015 person, sample adult, and
cancer files were merged together.
The sample for this study consisted of women who were between the ages of 21
and 65. Women who had a hysterectomy or a history of cervical cancer were excluded.
The outcome variable was cervical cancer screening adherence. Cervical cancer
screening adherence was defined as having had at least one Pap test during the last 3
years, or for those 30-65 as having had a Pap test and HPV test during the last 5 years.
Screening adherence was assessed by the following questions: “When did you have your
most recent pap test?” “Did you have an HPV test with your most recent pap?”
Demographic, acculturation, access to care and utilization, chronic conditions,
and health behaviors and knowledge variables were explored as predictors for Pap test
adherence among unmarried women. Demographic variables included age,
race/ethnicity, marital status, education level, and employment status. Marital status
included the following categories: married, widowed, separated, divorced, and never
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married. Women who reported themselves as widowed, separated, or divorced were
considered to be previously married in this study. Previously married and never married
women were then combined to create a variable for unmarried women.
Acculturation was assessed using the geographic region of birth, English
proficiency, and period of U.S. residence variables. Access to care variables included
insurance type, office visits in past 12 months, and usual source of care. A chronic
condition variable combined hypertension, high cholesterol, congestive heart failure,
heart disease, emphysema, chronic obstructive pulmonary disease, asthma, cancer, or
diabetes. Health behaviors and knowledge included BMI level, ever heard of HPV, ever
received HPV vaccine, age when first child born, doctor recommended pap test, birth
control use, alcohol drinking status, smoking status, flu shot, risk perception of breast
cancer, and reported health status.
Descriptive analyses were first performed. Then, a multiple logistic regression
model was used to examine the relationship between selected variables and cervical
cancer screening adherence among married and unmarried women, and analysis was then
stratified by race to determine significant predictors among unmarried women.
Backward elimination and stepwise procedures were used for the selection of variables
into the model. Multicollinearity was tested for to ensure predictors were not highly
correlated. SAS 7.12 was used to perform the analysis. All analyses included statistical
weights to account for the complex survey design, oversampling, post-stratification, and
survey nonresponse. Weight, stratum, and cluster variables were used to specify the
sample design. SAS Proc SURVEY and its statements were used to allow for correct
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estimation from a complex sample. This study was determined to be non human subjects
research due to the use of publically available de-identified data.

Results
The sample consisted of 10,643 women between the ages of 21 and 65 without a
hysterectomy or history of cancer and who reported their marital status. Table 2.1 shows
the distribution of characteristics by marital status among women who adhered to cervical
cancer screening guidelines. The highest percentage of married (32.1%) and previously
married (49.8%) women were 50 to 65 years old; whereas the highest percentage of never
married women was 21 to 29 years old (43.2%). The majority of women had completed
some college (29.5% of married women, 36.3% previously married, 35.5% never
married) or were college graduates (40.4% of married women, 27.3% previously married,
32.5% never married). More women were employed in the year prior to the study (71.5%
of married women, 73.3% previously married, 77.7% never married) as compared to
those who were not employed (28.5% of married women, 26.7% previously married,
22.3% never married).
The majority of women spoke English very well or well (90.3% of married
women, 93.7% previously married, 94.1% never married) and were born in the United
States (73.8% of married women, 80.7% previously married, 83.8% never married).
Women with private insurance (74.1% of married women, 56.7% previously married,
56.5% never married), four or more office visits (38.5% of married women, 43.3%
previously married, 38.2% never married), and a usual source of care (88.6% of married
women, 88.1% previously married, 81.7% never married) had the highest percentages
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across all marital statuses. A greater proportion of women did not have chronic
conditions among married (56.0%) and never married women (60.6%). For previously
married women, a greater proportion had a chronic condition (56.4%).
A higher proportion of women were obese among previously married (38.4%) and
unmarried women (37.2%); whereas women with normal body mass index represented
the highest proportion among married women (39.9%). Women who had heard of HPV,
had not received an HPV shot, had a doctor recommend a Pap test, were not currently
taking birth control pills, were current drinkers, were never smokers, had a flu shot in the
past 12 months, perceived themselves as less likely at risk for breast cancer, and had an
excellent or good self-reported health status represented the majority of respondents with
cervical cancer screening adherence across all marital statuses. There was a greater
proportion of married (43.6%) and previously married (38.7%) women with their age at
the birth of their first child being 21 to 29 years, whereas never married women had a
higher proportion if they never gave birth (58.8%).
Women who were previously married or never married were combined for a total
of 5,707 unmarried women, representing 33,400,724 women in the United States (Table
2.2). There were 4,936 married women, representing 42,328,266 women. We performed
a multivariable analysis to calculate the odds ratios for cervical cancer screening
adherence, adjusting for other variables. Age, employment status, number of physician
office visits in the past 12 months, usual source of care, HPV knowledge, receipt of HPV
vaccine, age when first child was born, birth control use, alcohol drinking status, smoking
status, receipt of flu shot in past 12 months, risk perception of breast cancer, and reported
health status were significant predictors of cervical cancer screening adherence among
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unmarried women. Among those variables, age, employment status, receipt of HPV
vaccine, risk perception of breast cancer, and reported health status were not significant
in married women. Unmarried women with all races combined and aged 30 to 39 years
had the highest odds of screening adherence (aOR 2.38, CI 1.171-3.31), whereas
Hispanic women aged 40 to 49 years had the highest odds (aOR 2.44, CI 1.24-4.80)
(Table 2.3). Unmarried women who were not employed last year (aOR 0.48, CI 0.380.62), had no physician office visits (aOR 0.58, CI 0.40-0.85), and did not have a usual
source of care (aOR 0.67, CI 0.50-0.89) had a lower odds of screening adherence,
regardless of race.
Among health behavior and knowledge variables, unmarried women who had
never heard of HPV (aOR 0.59, CI 0.46-0.76), had never received an HPV shot (aOR
0.50, CI 0.34-0.75), were not currently taking birth control pills (aOR 0.33, CI 0.23,
0.47), did not get a flu shot in the past 12 months (aOR 0.62, CI 0.48, 0.80), and
perceived their risk of breast cancer as less likely or about as likely as the average women
(aOR 0.66, CI 0.47-0.92) had lower odds of cervical cancer screening adherence,
regardless of race. Unmarried women overall (aOR 3.72, CI 2.13-6.49) and unmarried
non-Hispanic white women (aOR 3.11, CI 1.64-5.90) who were over 30 years of age had
the highest odds of screening adherence as compared to unmarried women who never
gave birth, whereas unmarried Hispanic women who were 21 to 29 years of age had the
highest odds (aOR 6.37, CI 3.53-11.48). Unmarried women overall (aOR 1.90, CI 1.432.51) and non-Hispanic white women (aOR 2.58, CI 1.69, 3.95) who were current
drinkers had the highest odds of screening adherence as compared to lifetime abstainers.
Unmarried women overall (aOR 0.65, CI 0.48-0.89) and non-Hispanic white women
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(aOR 0.52, CI 0.33-0.79) who reported fair or poor health status had lower odds of
screening adherence as compared to women who reported excellent or good health status.

Discussion
We assessed predictors for cervical cancer screening among married and
unmarried women in the United States. To our knowledge, there are few studies with a
similar sample of unmarried women in the United States to compare our results. Overall,
52% of women in this study were unmarried, and 79% of unmarried women adhered to
cervical cancer screening guidelines. Our finding of 79% cervical cancer screening
adherence among unmarried women was consistent with a study using the Behavioral
Risk Factor Surveillance System Survey (Hanske et al., 2016). The proportion of
unmarried women adhering to screening guidelines has been shown to be lower when
compared to women of all marital status (83%) (White et al., 2017).
Failure to adhere to cervical cancer screening guidelines has been shown to be the
primary reason for late-stage diagnosis of cervical cancer (Saghari et al., 2015). It has
been suggested that marital status affects the diagnosis and prognosis to cancer. Married
women were more likely to be diagnosed at an early stage of cervical cancer as compared
to unmarried women (El-Haddad et al., 2015). Single/divorced/widowed and never
married women as compared to married women were shown to have the strongest
predictors of delayed-stage cervical cancer (Saghari et al., 2015). This suggests that
married women are more likely to adhere to screening guidelines as compared to other
marital groups. Marriage has also been linked to increased survival among cancer
patients (El-Haddad et al., 2015). Marital status has been shown to predict survival
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outcome in other cancers, with married patients having a better survival outcome as
compared to unmarried patients. Married women may have increased social support,
healthier behaviors, and higher income, which in turn may improve outcomes related to
cancer therapies and rehabilitation (Wang et al., 2017). Increased financial resources
may also lead to reliable transportation (Baine et al., 2011).
Our analysis showed that married, previously married and unmarried women
differ with regard to age, race/ethnicity, education level, employment level, geographic
region of birth, English language proficiency, period of United States residency, health
care coverage, number of physician office visits, having a usual source of care, having a
chronic condition, body mass index, HPV knowledge, receipt of HPV vaccination, age
when first child was born, birth control use, alcohol drinking status, smoking status,
receipt of flu shot in past 12 months, and reported health status.
Unmarried women aged 30 to 39 years of age had the highest odds of screening
adherence (aOR 2.38, CI 1.171-3.31), similar to that of women in all marital statuses
combined. The strongest predictor was the age the first child was born. One theory
could be that, without the social support of a spouse, older maternal age may bring more
independence and maturity to make better decisions such as visiting a doctor’s office than
a younger maternal age. In addition, being pregnant leads to the possibility of more
doctor office visits, particularly with a specialist where cervical cancer screening is
conducted (Hellquist, Czene, Hjalm, Nystrom, & Jonsson, 2014; Merrill, Fugal, Novilla,
& Raphael, 2005).
Previous studies have found employed women are more likely to adhere to
cervical cancer screening as compared to unemployed women (Clark et al., 2009).
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Unmarried women may be more likely to depend on their employment for financial
stability; whereas married women may receive some financial support from their spouse.
Unmarried women may benefit from physicians who have evening and weekend
appointments for screening (Clark et al., 2009).
The effect of marriage on cervical cancer screening adherence could be explained
by spouses monitoring each other’s health and promoting healthy behaviors. Married
couples may feel responsible for each other’s health, leading to encouragement of a
healthy lifestyle (El-Haddad et al., 2015). Marriage may influence healthy behaviors,
including diet, exercise, and health screenings (Baine et al., 2011). All of these factors
are known to promote health. Married couples also have better social support, which
improves feelings of happiness, acceptance, and self-efficacy (Baine et al., 2011).
Emotional support has been found to increase cancer screening adherence (El-Haddad et
al., 2015).
When unmarried women were stratified by race, similar patterns were found for
each group as were found for the overall unmarried group. Women who were employed,
had more than two office visits, and had a usual source of care had higher odds of
adhering to screening. Hispanic women with more than four office visits had three times
higher odds of adhering to cervical cancer screening as compared to only one office visit.
More office visits may provide more opportunities for patient education.
Limitations of this study included self-reported data, which may not accurately
capture cervical cancer screening adherence as a result of recall bias, social desirability,
and over-reporting of Pap test utilization. Women may also erroneously believe their
pelvic exam included a Pap test. In addition, the NHIS survey is administered to people
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with landline telephones. Therefore, the results of this study may be generalizable only
to women with a landline telephone. Results from an NHIS survey suggested an
increasing trend with Americans who only have wireless telephones (Blumberg & Lake,
2017).
Public health interventions targeting unmarried women are needed to promote
cervical cancer screening. Future studies should explore opportunities, such as physician
recommendations, to introduce unmarried women to the benefits of adhering to screening
recommendation.

REFERENCES
Baine, M., Sahak, F., Lin, C., Chakraborty, S., Lyden, E., & Batra, S.K. (2011). Marital
status and survival in pancreatic cancer patients: A SEER based analysis. Plos One,
6(6), 1-9.
Benard, V.B., Thomas, C.C., King, J., Massetti, G.M., Doria-Rose, P., & Saraiya, M.
(2014). Vital Signs: Cervical cancer incidence, mortality, and screening – United States,
2007-2012. Morbidity and Mortality Weekly Report, 63, 1-6.
Blumberg, S.J., & Luke, J.V. (2017). Wireless substitution: Early release of estimates
from the National Health Interview Survey, July-December 2016. National Center for
Health Statistics.
Census Bureau. (2017). Facts for features: Unmarried and single Americans week.
Retrieved from https://www.census.gov/newsroom/facts-for-features/2017/singleamericans-week.html.
Centers for Disease Control and Prevention (2018). About the National Health Interview
Survey. Retrieved from https://www.cdc.gov/nchs/nhis/about_nhis.htm.
Chen, H., Kessler, C.L., Mori, N., & Chauhan, S.P. (2012). Cervical cancer screening in
the United States, 1993-2010: Characteristics of women who are never screened.
Journal of Women’s Health, 21(11), 1132-1138.
Clark, M.A., Rogers, M.L., Armstrong, G.F., Rakowski, W., Bowen, D.J., Hughes, T., &
McGarry, K.A. (2009). Comprehensive cancer screening among unmarried women aged

83

40-75 years: Results from the cancer screening project for women. Journal of Women’s
Health, 18(4), 451-459.
El-Haddad, B., Dong, F., Kallail, K.J., Hines, R.B., & Ablah, E. (2015). Association of
marital status and colorectal cancer screening participation in the USA. Colorectal
Disease, 17(5), O108-O114.
Hanske, J., Meyer, C.P., Sammon, J.D., Choueiri, T.K., Menon, M., Lipsitz,
S.R.,…Trinh, Q. (2016). The influence of marital status on the use of breast, cervical,
and colorectal cancer screening. Preventive Medicine, 89, 140-145.
Hellquist, B.N., Czene, K., Hjalm, A., Nystrom, L., & Jonsson, H. (2014). Effectiveness
of population-based service screening with mammography for women ages 40 to 49 years
with high or low risk of breast cancer: Socioeconomic status, parity, and age at birth of
first child. Cancer, 121(2), 251-258.
Merrill, R.M., Fugal, S., Novilla, L.B., & Raphael, M.C. (2005). Cancer risk associated
with early and late maternal age at first birth. Gynecologic Oncology, 96(3), 583-593.
National Cancer Institute. (2018). SEER cancer stat facts: Cervical cancer. Retrieved
from https://seer.cancer.gov/statfacts/html/cervix.html.
National Center for Health Statistics, Centers for Disease Control and Prevention. (2017).
National Health Interview Survey 2015 data release. Retrieved from
https://www.cdc.gov/nchs/nhis/nhis_2015_data_release.htm.
Office of Disease Prevention and Health Promotion. (2018). Cancer, Healthy People
2020. Retrieved from https://www.healthypeople.gov/2020/topicsobjectives/topic/cancer/objectives.
Politi, M.C., Clark, M.A., Rogers, M.L., McGarry, K., & Sciamanna, C.N. (2008).
Patient-provider communication and cancer screening among unmarried women. Patient
Education and Counseling, 73(2), 251-255.
Saghari, S., Ghamsary, M., Marie-Mitchell, A., Oda, K., & Morgan, J.W. (2015).
Sociodemographic predictors of delayed-versus early-stage cervical cancer in California.
Annals of Epidemiology, 25(4), 250-255.
U.S. Preventive Services Task Force. (2016). Final Update Summary: Cervical Cancer:
Screening. Retrieved from
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/ce
rvical-cancer-screening.
Wang, H., Wang, L., Kabirov, I., Peng, L., Chen, G., Yang, Y.,…Xu, W. (2017). Impact
of marital status on renal cancer patient survival. Oncotarget, 8(41), 1-10.

84

Watson, M., Benard, V., King, J., Crawford, A., & Saraiya, M. (2017). National
assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health
Interview Survey. Preventive Medicine, 100, 243-247.
White, A., Thompson, T.D., White, M.C., Sabatino, S.A., de Moor, J., Doria-Rose,
P.V.,… Richardson, L.C. (2017). Cancer screening test use – United States, 2015.
Morbidity and Mortality Weekly Report, 66 (8), 201-206.

85

Table 2.1: Characteristics of women by marital status - National Health Interview Survey, United States, 2015
(N=10,643)
Variables
Total
Weighted
Adherence (weighted %)

Married
4,936
42,328,266
85.5

Previously Married
2,473
12,944,074
80.6

Never Married
3,234
20,456,650
74.5

P-Value

Demographics
Age
21-29 years
30-39 years
40-49 years
50-65 years

686 (13.9%)
1415 (28.7%)
1216 (24.6%)
1619 (32.8%)

123 (5.0%)
449 (18.2%)
595 (24.1%)
1306 (52.8%)

1486 (45.6%)
875 (27.1%)
439 (13.6%)
444 (13.7%)

<0.0001

Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Asian
Other

3126 (63.3%)
988 (20.0%)
336 (6.8%)
436 (8.8%)
50 (1.0%)

1445 (58.4%)
461 (18.6%)
437 (17.7%)
91 (3.7%)
39 (1.6%)

1483 (45.9%)
688 (21.3%)
823 (25.4%)
175 (5.4%)
65 (2.0%)

<0.0001

Highest level of school completed
Less than high school
High school graduate or GED
Some college or associate degree
College graduate

549 (11.1%)
931 (18.9%)
1454 (29.5%)
1990 (40.4%)

330 (13.4%)
567 (23.0%)
894 (36.3%)
674 (27.3%)

356 (11.0%)
679 (21.0%)
1144 (35.5%)
1048 (32.5%)

<0.0001

Employed last year
Yes
No

3258 (71.5%)
1405 (28.5%)

1812 (73.3%)
660 (26.7%)

2511 (77.7%)
721 (22.3%)

<0.0001
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Acculturation
Geographic region of birth
United States
Mexico, Central America, Caribbean, South America
Europe, Russia
Africa
Middle East, Asia
Elsewhere

3631 (73.6%)
711 (14.4%)
99 (2.0%)
56 (1.1%)
399 (8.1%)
35 (0.7%)

1994 (80.6%)
324 (13.1%)
46 (1.9%)
29 (1.2%)
71 (2.9%)
9 (0.4%)

2704 (83.7%)
355 (11.0%)
37 (1.1%)
26 (0.8%)
98 (3.0%)
12 (0.4%)

<0.0001

How well is English spoken
Very well, well
Not well, not at all

4457 (90.3%)
479 (9.7%)

2318 (93.7%)
155 (6.3%)

3042 (94.1%)
192 (5.9%)

0.0012

Period of U.S. Residence
U.S. born
In U.S. ≥ 10 years
In U.S. < 10 years

3631 (73.8%)
993 (20.2%)
295 (6.0%)

1994 (80.7%)
419 (16.9%)
59 (2.4%)

2704 (83.8%)
403 (12.5%)
120 (3.7%)

<0.0001

Access to Care and Utilization
Health care coverage
Private
Medicaid and other public
Other coverage
Uninsured

3585 (74.1%)
459 (9.5%)
249 (5.1%)
543 (11.2%)

1346 (56.7%)
551 (23.2%)
145 (6.1%)
331 (13.9%)

1808 (56.5%)
846 (26.5%)
81 (2.5%)
463 (14.5%)

<0.0001

Outpatient clinic visits - past 12 months
None
1
2-3
4+

688 (14.0%)
902 (18.3%)
1442 (39.2%)
1899 (38.5%)

351 (14.2%)
376 (15.2%)
672 (27.2%)
1069 (43.3%)

544 (16.8%)
557 (17.2%)
896 (27.7%)
1232 (38.2%)

0.0006
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Usual source of care
Has usual source
None or hospital emergency department

4344 (88.6%)
558 (11.4%)

2168 (88.1%)
292 (11.9%)

2623 (81.7%)
589 (18.3%)

<0.0001

Chronic Conditions
No
Yes

2727 (56.0%)
2144 (44.0%)

1056 (43.6%)
1368 (56.4%)

1938 (60.6%)
1258 (39.4%)

<0.0001

Health Behaviors and Knowledge
Body Mass Index
<18.5
18.5-24.9
25-29.9
>=30

93 (1.9%)
1945 (39.9%)
1297 (26.6%)
1538 (31.6%)

48 (2.0%)
820 (33.6%)
637 (26.1%)
937 (38.4%)

85 (2.7%)
1139 (35.7%)
779 (24.4%)
1187 (37.2%)

<0.0001

Ever heard of HPV
Yes
No

3670 (76.2%)
1149 (23.8%)

1693 (71.5%)
674 (28.5%)

2474 (77.4%)
724 (22.6%)

<0.0001

Ever received HPV shot/vaccine
Yes
No

337 (7.2%)
4360 (92.8%)

109 (4.7%)
2204 (95.3%)

726 (23.3%)
2386 (76.7%)

<0.0001

Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

896 (18.3%)
1003 (20.5%)
2133 (43.6%)
864 (17.6%)

399 (16.3%)
796 (32.6%)
945 (38.7%)
304 (12.4%)

1890 (58.8%)
667 (20.7%)
557 (17.3%)
102 (3.2%)

<0.0001
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Doctor recommended pap test
Yes
No
Did not see a doctor in the past 12 months

2647 (54.6%)
1984 (40.9%)
215 (4.4%)

1318 (54.8%)
979 (40.7)
109 (4.5%)

1592 (50.4%)
1415 (44.8%)
154 (4.9%)

0.2218

Currently taking birth control pills, implants, or shots
Yes
No

743 (15.2%)
4147 (84.8%)

240 (9.9%)
2194 (90.1%)

889 (27.7%)
2316 (72.3%)

<0.0001

Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

1199 (24.4%)
559 (11.4%)
3151 (64.2%)

463 (18.8%)
422 (17.2%)
1574 (64.0%)

648 (20.1%)
293 (9.1%)
2278 (70.8%)

<0.0001

Smoking status
Never smoker
Former smoker
Current smoker

3581 (72.6%)
832 (16.9%)
521 (10.6%)

1356 (55.0%)
490 (19.9%)
620 (25.1%)

2270 (70.3%)
390 (12.1%)
570 (17.6%)

<0.0001

Flu shot past 12 months
Yes
No

2146 (43.5%)
2786 (56.5%)

1035 (41.9%)
1434 (58.1%)

1121 (34.7%)
2105 (65.3%)

<0.0001

Risk of breast cancer compared to average women
More likely
Less likely, about as likely

529 (11.4%)
4122 (88.6%)

311 (13.4%)
2004 (86.6%)

337 (11.0%)
2740 (89.0%)

0.5782

Reported health status
Excellent, very good, or good
Fair or poor

4527 (91.7%)
409 (8.3%)

2025 (81.9%)
448 (18.1%)

2847 (88.1%)
386 (11.9%)

<0.0001
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Table 2.2: Adjusted model of cervical cancer screening adherence by marital status - National Health Interview Survey,
United States, 2015
Variables

Married

Unmarried

3,684
32,168,699
85.5%

3,999
23,020,201
78.6%

Demographics
Age
21-29 years
30-39 years
40-49 years
50-65 years

1.00
1.12 (0.74, 1.69)
0.73 (0.48, 1.13)
0.80 (0.53, 1.21)

1.00
2.38*** (1.71, 3.31)
2.08*** (1.48, 2.92)
1.59** (1.13, 2.24)

Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Asian
Other

1.00
1.08 (0.78, 1.48)
1.40 (0.87, 2.25)
0.62* (0.42, 0.90)
0.62 (0.16, 2.49)

1.00
0.95 (0.69, 1.31)
1.74*** (1.28, 2.36)
0.85 (0.54, 1.35)
0.95 (0.35, 2.55)

Employed last year
Yes
No

1.00
0.80 (0.62, 1.03)

1.00
0.48*** (0.38, 0.62)

Total cervical cancer screening adherence
Weighted
Adherence (weighted %)
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Access to Care and Utilization
Office visits - past 12 months
None
1
2-3
4+

0.33*** (0.23, 0.48)
1.00
1.40* (1.01, 1.93)
1.92*** (1.37, 2.70)

0.58** (0.40, 0.85)
1.00
1.53* (1.06, 2.22)
1.76** (1.26, 2.47)

Usual source of care
Has usual source
None or hospital emergency department

1.00
0.58** (0.42, 0.81)

1.00
0.67** (0.50, 0.89)

Health Behaviors and Knowledge
Ever heard of HPV
Yes
No

1.00
0.43*** (0.33, 0.55)

1.00
0.59*** (0.46, 0.76)

Ever received HPV shot/vaccine
Yes
No

1.00
0.69 (0.38, 1.26)

1.00
0.50*** (0.34, 0.75)

Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

1.00
1.04 (0.72, 1.49)
1.22 (0.89, 1.68)
1.64* (1.09, 2.46)

1.00
3.10*** (2.43, 3.95)
2.71*** (2.06, 3.58)
3.72*** (2.13, 6.49)

Currently taking birth control pills, implants,
or shots
Yes
No

1.00
0.60** (0.42, 0.86)

1.00
0.33*** (0.23, 0.47)
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Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

1.00
0.93 (0.63, 1.39)
1.37* (1.02, 1.86)

1.00
1.06 (0.74, 1.52)
1.90*** (1.43, 2.51)

Smoking status
Never smoker
Former smoker
Current smoker

1.00
0.93 (0.66, 1.3)
0.42*** (0.29, 0.61)

1.00
1.01 (0.73, 1.40)
0.75 (0.56, 1.00)

Flu shot past 12 months
Yes
No

1.00
0.63*** (0.49, 0.81)

1.00
0.62*** (0.48, 0.80)

Risk of breast cancer compared to average
women
More likely
Less likely, about as likely

1.00
1.14 (0.80, 1.61)

1.00
0.66* (0.47, 0.92)

Reported health status
Excellent, very good, or good
Fair or poor

1.00
0.82 (0.53, 1.26)

1.00
0.65** (0.48, 0.89)

*<0.05, **<0.01, ***<0.001
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Table 2.3: Adjusted model of cervical cancer screening adherence by race among unmarried women - National Health Interview
Survey, United States, 2015
Variables

Overall

Non-Hispanic White

Non-Hispanic Black

Hispanic

Total
Weighted

3,999
23,020,201
78.6

2,087
13,132,995
77.9

1,055
5,523,866
83.8

759
3,797,076
77.5

Demographics
Age
21-29 years
30-39 years
40-49 years
50-65 years

1.00
2.38*** (1.71, 3.31)
2.08*** (1.48, 2.92)
1.59** (1.13, 2.24)

1.00
2.61** (1.46, 4.65)
1.73* (1.05, 2.84)
1.33 (0.82, 2.15)

1.00
1.54 (0.74, 3.19)
1.30 (0.71, 2.40)
0.94 (0.49, 1.77)

1.00
1.79* (1.08, 2.96)
2.44* (1.24, 4.80)
1.69 (0.92, 3.11)

Employed last year
Yes
No

1.00
0.48*** (0.38, 0.62)

1.00
0.47*** (0.32, 0.69)

1.00
0.43*** (0.27, 0.69)

1.00
0.45*** (0.28, 0.71)

Access to Care and Utilization
Outpatient clinic visits - past 12 months
None
1
2-3
4+

0.58** (0.40, 0.85)
1.00
1.53* (1.06, 2.22)
1.76** (1.26, 2.47)

0.64 (0.36, 1.14)
1.00
1.87** (1.08, 3.23)
1.72** (1.04, 2.83)

0.39** (0.19, 0.79)
1.00
1.49 (0.75, 2.96)
1.21 (0.67, 2.16)

0.85 (0.47, 1.54)
1.00
1.38 (0.78, 2.45)
2.95*** (1.64, 5.30)

Usual source of care
Has usual source
None or hospital emergency department

1.00
0.67** (0.50, 0.89)

1.00
0.52** (0.35, 0.77)

1.00
0.80 (0.48, 1.35)

1.00
0.74 (0.42, 1.28)

Adherence (weighted %)
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Health Behaviors and Knowledge
Ever heard of HPV
Yes
No

1.00
0.59*** (0.46, 0.76)

1.00
0.65* (0.46, 0.93)

1.00
0.37*** (0.24, 0.58)

1.00
0.55* (0.33, 0.91)

Ever received HPV shot/vaccine
Yes
No

1.00
0.50*** (0.34, 0.75)

1.00
0.51* (0.29, 0.92)

1.00
0.72 (0.37, 1.42)

1.00
0.41** (0.24, 0.70)

Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

1.00
3.10*** (2.43, 3.95)
2.71*** (2.06, 3.58)
3.72*** (2.13, 6.49)

1.00
2.42*** (1.67, 3.52)
2.79*** (1.82, 4.28)
3.11*** (1.64, 5.90)

1.00
2.32*** (1.49, 3.63)
1.43 (0.83, 2.48)
2.61 (0.96, 7.07)

1.00
6.24*** (3.67, 10.60)
6.37*** (3.53, 11.48)
14.88*** (4.42, 50.12)

Currently taking birth control pills,
implants, or shots
Yes
No

1.00
0.33*** (0.23, 0.47)

1.00
0.31*** (0.20, 0.49)

1.00
0.40* (0.17, 0.94)

1.00
0.36*** (0.23, 0.57)

Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

1.00
1.06 (0.74, 1.52)
1.90*** (1.43, 2.51)

1.00
1.33 (0.80, 2.21)
2.58*** (1.69, 3.95)

1.00
0.74 (0.38, 1.43)
1.10 (0.68, 1.78)

1.00
0.68 (0.35, 1.34)
1.50 (0.91, 2.47)

1.00
1.01 (0.73, 1.40)
0.75 (0.56, 1.00)

1.00
1.07 (0.72, 1.58)
0.88 (0.61, 1.28)

1.00
1.07 (0.59, 1.92)
0.91 (0.55, 1.49)

1.00
0.59 (0.20, 1.68)
0.91 (0.51, 1.63)

1.00
0.62*** (0.48, 0.80)

1.00
0.65* (0.46, 0.91)

1.00
0.64 (0.41, 1.02)

1.00
0.55* (0.32, 0.93)

Smoking status
Never smoker
Former smoker
Current smoker
Flu shot past 12 months
Yes
No
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Risk of breast cancer compared to
average women
More likely
Less likely, about as likely

1.00
0.66* (0.47, 0.92)

1.00
0.66* (0.45, 0.98)

1.00
0.63 (0.30, 1.31)

1.00
0.37** (0.18, 0.78)

Reported health status
Excellent, very good, or good
Fair or poor

1.00
0.65** (0.48, 0.89)

1.00
0.52** (0.33, 0.79)

1.00
0.80 (0.49, 1.31)

1.00
1.54 (0.80, 2.98)

*<0.05, **<0.01, ***<0.001
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CHAPTER VI.
MANUSCRIPT 3
Physician recommendation and patient adherence to cervical cancer screening
among women aged 21 to 65 years in the United States, 2015 National Health
Interview Survey

Abstract
Background: Physician recommendation has been shown to be a significant predictor of
cancer screening. Few studies have investigated differences in patients who receive
physician recommendation for cervical cancer screening versus those who adhere to
physician recommendations. The current study explores the gap between physician
recommendation and patient adherence in a nationally representative sample of women in
the United States. Our objective is to determine the proportion of women who received a
physician recommendation and proportion of those women who adhered to the physician
recommendation. Methods: The data source for this study was the 2015 National Health
Interview Survey (NHIS). The sample for this study consisted of women who were
between the ages of 21 and 65 who received a physician recommendation for cervical
cancer screening. The two outcome variables were receiving a physician
recommendation and adherence to the physician recommendation for cervical cancer
screening. Demographic, acculturation, access to care and utilization, chronic conditions,
and health behaviors and knowledge variables were explored as predictors for receiving a
physician recommendation and adherence to the physician recommendation for cervical
cancer screening. A multiple logistic regression model was used to examine the
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relationship between select variables and women who received a physician
recommendation, and then between the same selected variables and adherence to
physician recommendation for cervical cancer screening. Results: Overall, 56% of
women with a current physician, reported that cervical cancer screening was
recommended to them in the past 12 months. For all respondents, race/ethnicity, health
care coverage, outpatient clinic visits, usual source of care, HPV knowledge, receiving an
HPV shot, age when first child born, and receiving a flu shot were significant predictors
of which respondents received a recommendation for cervical cancer screening.
Variables that were significant predictors of adherence to physician recommendation for
screening were education level, employment status, English proficiency, outpatient clinic
visits, usual source of care, age when first child born, birth control use, alcohol use,
smoking status, flu shot, and reported health status. Conclusion: This study suggests that
a strategy to further increase cervical cancer screening rates nationally is for physicians to
recommend screening to all patients who might benefit. Physician recommendation plays
an important role in adherence to cervical cancer screening.

Background
There are an estimated 13,240 new cases of invasive cervical cancer and 4,170
deaths occurring in 2018 (ACS, 2018). Incidence rates of invasive cervical cancer
declined from 1975 (14.8 per 100,000) to 2014 (6.9 per 100,000), mainly due to
screening. The decline has slowed recently, with the overall incidence from 2005 to 2014
being stable. Similarly, the pace of reduction for mortality rate has slowed, with a
decrease of 0.8% per year from 2006 to 2015. The 5-year survival rate for cervical
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cancer is 92% when the cancer is diagnosed in a localized stage, but it falls to 57% and
17% when diagnosed in regional and distant-stage, respectively (ACS, 2018).
Physician recommendation has been shown to be a significant predictor of cancer
screening. Conversely, the lack of physician recommendation is reported as a reason
why patients did not adhere to screening guidelines for cancers, such as colorectal cancer
(Coughlin et al., 2005; Hudson et al., 2012; Jibara, Jandorf, Fodera,& DuHamel, 2011;
Shokar, Nguyen-Oghalai, & Wu, 2009; D. Wallace, Baltrus, T. Wallace, Blumenthal, &
Rust, 2013; ).
While physician recommendation has been studied with colorectal cancer and
breast cancer, few studies have investigated differences in patients who receive physician
recommendation for cervical cancer screening versus those who adhere to physician
recommendations. The current study explores the gap between physician
recommendation and patient adherence in a nationally representative sample of women in
the United States. Our objective is to determine the proportion of women who received a
physician recommendation and proportion of those women who adhered to the physician
recommendation. This will identify patient populations that could benefit from physician
recommendations and further attention to cervical cancer screening, which could increase
the number of women who adhere to screening guidelines. For those who did not follow
their physician’s recommendation, we explored the reasons for not obtaining a Pap test.

Methods
The data source for this study was the 2015 National Health Interview Survey
(NHIS) (National Center for Health Statistics, CDC, 2017). The NHIS is a cross-

98

sectional household interview survey with a multistage area probability design that
allows for representative sampling of household and non-institutional group quarters.
The sampling plan is a sample of clusters of addresses in primary sampling units, which
consist of a county, small group of contiguous counties, or a metropolitan statistical area
(CDC, 2018).
The NHIS questionnaire had a core set supplemental sets of questions. The core
questionnaire consisted of Household, Family, Sample Adult, and Sample Child
components. The supplemental questions included topics such as Healthy People
objectives, cancer screening, complementary and alternative medicine, children’s mental
health, and healthcare utilization (CDC, 2018). The 2015 Person, Sample Adult, and
Cancer files were merged together to create one dataset. The sample for this study
consisted of women who were between the ages of 21 and 65 who self-reported receiving
a physician recommendation for cervical cancer screening. Women who had a
hysterectomy or a history of cervical cancer were excluded. The two outcome variables
were: receiving a physician recommendation and adherence to the physician
recommendation for cervical cancer screening. Cervical cancer screening adherence was
defined by having had at least one Pap test during the last 3 years, or for those 30-65 by
having had a Pap test and HPV test during the last 5 years. Screening adherence was
assessed by the following question: “When did you have your most recent pap test?”
“Did you have an HPV test with your most recent pap?”
Demographic, acculturation, access to care and utilization, chronic conditions,
and health behaviors and knowledge variables were explored as predictors for Pap test
adherence among unmarried women. Demographic variables included age,
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race/ethnicity, marital status, education level, and employment status. Acculturation was
assessed using the geographic region of birth, English proficiency, and period of U.S.
residence variables.
Access to care variables included insurance type, office visits in past 12 months,
and usual source of care. A chronic condition variable combined had hypertension, high
cholesterol, congestive heart failure, heart disease, emphysema, chronic obstructive
pulmonary disease, asthma, cancer, or diabetes. Health behaviors and knowledge
included BMI level, ever heard of HPV, ever received HPV vaccine, age when first child
born, doctor recommended pap test, birth control use, alcohol drinking status, smoking
status, flu shot, risk perception of breast cancer, and reported health status.
A multiple logistic regression model was used to examine the relationship first
between selected variables and women who received a physician recommendation, and
then between the same selected variables and adherence to physician recommendation for
cervical cancer screening. Backward elimination and stepwise procedures were used for
the selection of variables into the model. Multicollinearity was tested for to ensure
predictors were not highly correlated. SAS 7.12 was used to perform the analysis. All
analyses included statistical weights to account for the complex survey design,
oversampling, post-stratification, and survey nonresponse. Weight, stratum, and cluster
variables were used to specify the sample design. SAS Proc SURVEY and its statements
were used to allow for correct estimation from a complex sample. This study was
determined to be non human subjects research due to the use of publically available deidentified data.
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Results
Overall, 56% of women, who self-reported having a current physician, had
cervical cancer screening recommended to them in the past 12 months. Younger age
(P=0.0022), being married (P=0.0001), being employed last year (P=0.0294), having
private health insurance (P<0.0001), having an outpatient clinic visit (P<0.0001), having
a usual source of care (P<0.0001), having no chronic conditions (P<0.0001), heard of
HPV (P<0.0001), having received an HPV vaccine dose (P=0.0397), never given birth
(P<0.0001), lifetime abstainer of alcohol (P=0.0087), flu shot (P<0.0001), and reporting
excellent or good health status (P=0.0083) were significant predictors of receiving a
physician recommendation for cervical cancer screening (Table 3.1).
Among patients who self-reported receiving a recommendation for cervical
cancer screening, predictors included younger age (P=0.0002), being married (P=0.0002),
higher education (P<0.0001), being employed last year (P<0.0001), having private health
insurance (P<0.0001), having an outpatient clinic visit (P<0.0001), having a usual source
of care (P<0.0001), heard of HPV (P<0.0001), having received an HPV vaccine
(P=0.0063), never given birth (P<0.0001), using birth control (P<0.0001), lifetime
abstainer of alcohol (P<0.0001), never smoker (P<0.0001), flu shot (P<0.0001), and
reporting excellent or good health status (P<0.0001) (Table 1). Race/ethnicity,
geographic region of birth, period of residence in the United States, chronic conditions,
body mass index, and breast cancer risk perception did not affect whether patients
adhered to cervical cancer screening recommendations.
Table 3.2 shows the adjusted odds ratios of receipt of physician recommendation
for cervical cancer screening and adherence to the physician recommendation. For all
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respondents, race/ethnicity, health care coverage, outpatient clinic visits, usual source of
care, HPV knowledge, receiving an HPV shot, age when first child was born, and
receiving a flu shot were significant predictors of which respondents received a
recommendation for cervical cancer screening. The odds of receiving a recommendation
were greater for women having four or more outpatient clinic visits (aOR 1.28, CI 1.111.48) and being older than 30 years when the first child was born (aOR 1.85, CI 1.522.24), as compared to one office visit and never giving birth, respectively. Respondents
who were Hispanic (aOR 0.73, CI 0.59-0.90), not having a usual source of care (aOR
0.75, CI 0.62-0.92), having never heard of HPV (aOR 0.83, CI 0.72-0.95), having never
received an HPV shot (aOR 0.76, CI 0.63-0.91), and not having had a flu shot in the past
12 months (aOR 0.83, CI 0.74-0.94) had lower odds of receiving a recommendation.
Age, marital status, employment status, chronic conditions, alcohol use, and reporting
excellent or good health status were no longer significant predictors of receipt of
physician recommendations in multivariable analysis.
Variables that were significant predictors of adherence to physician
recommendation for screening were education level, employment status, English
proficiency, outpatient clinic visits, usual source of care, age when first child born, birth
control use, alcohol use, smoking status, flu shot, and reported health status. The odds of
adhering to physician recommendations were greater for women who were college
graduates (aOR 1.51, CI 1.03-2.21), having four or more outpatient clinic visits (aOR
1.85, CI 1.26-2.70), being older than 30 years when first child born (aOR 2.87, CI 1.864.41), and being current drinkers (aOR 2.87, CI 1.86-4.41). Respondents who were not
employed last year (aOR 0.63, CI 0.46-0.87), not having had a usual source of care (aOR
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0.64, CI 0.44-0.93), not taking birth control pills (aOR 0.51, CI 0.31-0.83), current
smokers (aOR 0.53, CI 0.38-0.73), not having had a flu shot in the past 12 months (aOR
0.52, CI 0.39-0.70), and reporting fair or poor health status (aOR 0.68, CI 0.47-0.99) had
lower odds of adhering to physician recommendations.
Among women who received a physician recommendation for cervical cancer
screening, 392 women provided a reason for why they have not been screened. The most
common reasons included: “Didn’t need it or didn’t know I needed it” (14.0%, CI 10.317.7), no problems (8.7%, CI 6.0-11.5), put it off (11.2%, CI 8.9-13.5), too expensive or
no insurance (18.8%, CI 13.4-24.2), too painful or embarrassing (5.5%, CI 3.0-8.1), no
reason/never thought about it (34.0%, CI 29.1-38.8) or other (7.8%, CI 5.1-10.5) (Table
3).

Discussion
We found no difference in receipt of physician recommendation and adherence by
race ethnicity, but Hispanic ethnicity was associated with lower odds of receiving a
physician recommendation. While non-Hispanic black women had lower odds of
receiving a physician recommendation as compared to non-Hispanic white women, they
had higher odds of adhering to physician recommendations. This study also found that
higher education and being employed increases the odds of adhering to physician
recommendations for screening.
Women who were born in Mexico, Central America, Caribbean, and South
America had the highest odds of receiving a physician recommendation. The physicianpatient relationship and subsequent communication regarding cancer screening is
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important for patients with language and cultural barriers (Coughlin et al., 2005; Juon et
al., 2003; Nguyen et al., 2002). Previous studies have shown that physician
recommendation for a Pap test is an important predictor of screening in Hispanic women
(Ngueyn et al., 2002; O’Malley et al., 2001).
Insurance type was important for physician recommendation but not in adherence
to the recommendation. Education level, employment status, and English proficiency
only played roles in adhering to physician recommendation but not in receiving physician
recommendation. Physicians may be less likely to recommend cancer screening if the
patient does not have insurance or is unable to otherwise pay for services (Wallace et al.,
2013).
The number of outpatient clinic visits significantly increased the odds of receiving
a physician recommendation and the odds of adhering to the recommendation. Women
with co-morbidities may visit their doctor more frequently, which would then be
consistent with studies that have reported patients with co-morbidities were more likely
to receive recommendations for cancer screening (Wallace et al., 2013).
Among reasons reported by women who did not adhere to cervical cancer
screening after a physician recommends it, some stated they did not know they needed it.
Some women believe that Pap tests are for women who are younger, sexually active, or
pregnant. This may lead them to think that routine screenings are not relevant to them.
Communications regarding sexual behavior during a clinic visit have been shown to
improve cancer screening rates (Politi et al., 2008).
Evidence has shown patient-provider communication to be a predictor of cancer
screening among women (Politi et al., 2008). Positive communications can lead to
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changes in health behavior, adherence to medical advice, increased understanding about
the importance of screening, and higher satisfaction with care. This may result in
increased cancer screening rates (Politi et al., 2008).
The main limitations of this study is self-reported data, which may not accurately
capture cervical cancer screening adherence as a result of recall bias, social desirability,
and over-reporting of Pap test utilization. Women may also erroneously believe their
pelvic exam included a Pap test, or they may not realize they had a Pap test during their
pelvic exam. In addition, women may not recall whether their physician provided a
recommendation. Self-report does not allow us to explore physician barriers to
understand why physicians may have been more likely to recommend or not recommend
screening.
This study suggests the physician recommendations may increase cervical cancer
screening rates. A strategy to further increase cervical cancer screening rates nationally
is for physicians to recommend screening to all patients who might benefit. Physician
recommendation plays an important role in adherence to cervical cancer screening. In
addition, strategies to address the reasons for non-adherence to cervical cancer screening
are needed. One such strategy could be sensitivity training for physicians on delivering
cervical cancer screening recommendations and on performing the tests. In addition to
recommending cervical cancer screening, physicians should consider communication
about sexual health to address any misconceptions about the risk of cervical cancer.
Comprehensive communication that includes cervical cancer screening
recommendations and sexual health may have a positive impact on screening adherence.
Future research should consider optimal approaches for communication with women to
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promote cervical cancer screening. Moreover, the type of physician, such as primary care
or gynecologist, providing the recommendation should be examined. In addition,
adherence to recommendations received from physicians should be compared to those
received from physician extenders, such as nurse practitioners. Some office visits do not
include face-to-face interactions with physicians, and instead a physician extender may
be the one to conduct the visit.
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Table 3.1: Receipt of and adherence to physician recommendation for cervical cancer screening - National Health
Interview Survey, United States, 2015 (N=9,958)
Variables

Received Physician Recommendation

Adherence to Physician Recommendation

Overall
Weighted

5,566
39,610,272

4,944
35,367,305

Total

Sample %

% Recommended
(weighted)

1132
1422
1188
1824

20.3
25.5
21.3
32.8

Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Asian
Other

3284
1061
825
327
69

Marital Status
Married
Widowed or Separated
Divorced
Never married
Highest level of school completed
Less than high school
High school graduate or GED
Some college or associate degree
College graduate

Demographics
Age
21-29 years
30-39 years
40-49 years
50-65 years

P-Value

Total

Sample %

% Adherence
(weighted)

52.1
54.7
58.1
58.7

0.0022

1029
1298
1070
1547

20.8
26.3
21.6
31.3

90.5
92.6
88.8
86.3

0.0002

59.0
19.1
14.8
5.9
1.2

57.5
53.5
54.0
54.3
45.8

0.0536

2898
951
751
282
62

58.6
19.2
15.2
5.7
1.3

89.3
88.5
91.4
87.8
87.3

0.4981

2647
420
898
1592

47.6
7.6
16.2
28.6

58.0
55.2
58.0
51.3

0.0001

2395
354
785
1403

48.5
7.2
15.9
28.4

91.3
87.0
86.2
86.6

0.0002

619
1098
1840
1996

11.1
19.8
33.1
35.9

56.4
55.4
55.3
57.1

0.7248

507
933
1642
1849

10.3
18.9
33.3
37.5

79.4
85.5
90.0
93.0

<.0001
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P-Value

Employed last year
Yes
No

4075
1489

73.2
26.8

55.2
58.5

0.0294

3684
1258

74.5
25.5

91.2
84.1

<.0001

4425
712

79.5
12.8

56.1
56.5

0.9767

3937
642

79.7

89.8
88.6

0.1094

96
48
256
26

1.7
0.9
4.6
0.5

54.2
57.3
54.0
57.0

How well is English spoken
Very well, well
Not well, not at all

5168
398

92.8
7.2

56.1
55.3

Period of U.S. Residence
U.S. born
In U.S. ≥ 10 years
In U.S. < 10 years

4425
909
223

79.6
16.4
4.0

Access to Care and Utilization
Health care coverage
Private
Medicaid and other public
Other coverage
Uninsured

3568
1057
249
576

65.5
19.4
4.6
10.6

Acculturation
Geographic region of birth
United States
Mexico, C. America, Caribbean,
S. America
Europe, Russia
Africa
Middle East, Asia
Elsewhere

80
44
221
18

13.0
1.6
0.9
4.5
0.4

84.8
89.7
87.3
70.4

0.7578

4585
359

92.7
7.3

89.2
90.1

0.6699

56.1
55.4
56.9

0.8828

3937
804
196

79.7
16.3
4.0

89.8
89.0
87.0

0.167

56.7
61.4
50.8
46.6

<.0001

3263
923
207
458

67.3
19.0
4.3
9.4

91.7
86.8
86.4
77.8

<.0001
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Outpatient clinic visits –
past 12 months
None
1
2-3
4+

505
904
1647
2507

9.1
16.3
29.6
45.1

39.8
52.6
57.8
60.6

<.0001

340
784
1504
2316

6.9
15.9
30.4
46.8

66.7
86.4
92.0
92.6

<.0001

Usual source of care
Has usual source
None or hospital emergency dept.

5022
515

90.7
9.3

57.8
42.5

<.0001

4533
389

92.1
7.9

90.5
77.8

<.0001

Chronic Conditions
No
Yes

2853
2638

53.9
49.9

53.6
59.3

<.0001

2543
2333

52.2
47.8

89.1
89.5

0.7198

Health Behaviors and Knowledge
Body Mass Index
<18.5
18.5-24.9
25-29.9
>=30

101
2013
1444
1926

1.8
36.7
26.3
35.1

45.4
55.0
56.5
57.3

0.0696

85
1792
1282
1710

1.7
36.8
26.3
35.1

85.8
89.9
89.6
88.5

0.5938

Ever heard of HPV
Yes
No

4309
1145

79.0
21.0

57.4
51.1

<.0001

3906
947

80.5
19.5

90.9
83.5

<.0001

Ever received HPV shot/vaccine
Yes
No

672
4615

12.7
87.3

59.6
55.3

0.0397

630
4071

13.4
86.6

93.3
88.8

0.0063
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Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

1505
1301
1976
755

27.2
23.5
35.7
13.6

49.8
56.9
57.9
63.6

<.0001

1298
1136
1781
706

26.4
23.1
36.2
14.3

86.7
87.8
90.5
92.7

0.0014

Currently taking birth control
pills, implants, or shots
Yes
No

1075
4455

19.4
80.6

58.3
55.6

0.1488

1010
3902

20.6
79.4

95.1
87.9

<.0001

Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

1114
709
3717

20.1
12.8
67.1

52.7
59.9
56.4

0.0087

962
599
3362

19.5
12.2
68.3

84.9
84.6
91.4

<.0001

Smoking status
Never smoker
Former smoker
Current smoker

3743
926
890

67.3
16.7
16.0

55.9
56.4
56.5

0.9178

3403
828
709

68.9
16.8
14.4

90.8
91.1
80.2

<.0001

Flu shot past 12 months
Yes
No

2477
3082

44.6
55.4

60.8
52.6

<.0001

2299
2639

46.6
53.4

93.4
85.9

<.0001

Risk of breast cancer compared
to average women
More likely
Less likely, about as likely

662
4651

7.0
49.2

60.0
56.0

0.0794

602
4126

12.7
87.3

90.6
89.2

0.4164

Reported health status
Excellent, very good, or good
Fair or poor

4847
719

87.1
12.9

55.5
61.1

0.0083

4346
598

87.9
12.1

90.2
82.3

<.0001

111

Table 3.2: Adjusted odds ratios of receipt of and adherence to physician recommendation for cervical cancer screening National Health Interview Survey, United States, 2015

Variables

Received Physician
Recommendation

Adherence to Physician
Recommendation

Overall
Weighted

4,797
42,768,435

4,280
36,708,797

Adjusted Odds Ratio

Adjusted Odds Ratio

1.00
0.73** (0.59, 0.90)
0.85 (0.71, 1.01)
0.98 (0.66, 1.47)
0.61 (0.33, 1.14)

1.00
1.08 (0.72, 1.64)
1.85** (1.23, 2.79)
0.93 (0.56, 1.57)
1.13 (0.37, 3.47)

Demographics
Race/Ethnicity
Non-Hispanic white
Hispanic
Non-Hispanic black
Asian
Other
Highest level of school completed
Less than high school
High school graduate or GED
Some college or associate degree
College graduate

-

Employed last year
Yes
No

-

0.64 (0.40, 1.02)
1.00
1.19 (0.84, 1.68)
1.51* (1.03, 2.21)

1.00
0.63** (0.46, 0.87)
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Acculturation
Geographic region of birth
United States
Mexico, C. America, Caribbean, S. America
Europe, Russia
Africa
Middle East, Asia
Elsewhere
How well is English spoken
Very well, well
Not well, not at all

1.00
1.46** (1.16, 1.84)
0.91 (0.58, 1.42)
1.35 (0.68, 2.68)
1.01 (0.66, 1.55)
1.09 (0.51, 2.34)
1.00
2.36* (1.22, 4.58)

Access to Care and Utilization
Health care coverage
Private
Medicaid and other public
Other coverage
Uninsured

1.00
1.28** (1.09, 1.49)
0.76* (0.58, 0.99)
0.91 (0.74, 1.13)

Outpatient clinic visits - past 12 months
None
1
2-3
4+

0.66*** (0.55, 0.80)
1.00
1.18* (1.01, 1.38)
1.28** (1.11, 1.48)

-
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0.34*** (0.22, 0.53)
1.00
1.53* (1.06, 2.21)
1.85** (1.26, 2.70)

Usual source of care
Has usual source
None or hospital emergency department

1.00
0.75** (0.62, 0.92)

1.00
0.64* (0.44, 0.93)

Health Behaviors and Knowledge
Ever heard of HPV
Yes
No

1.00
0.83** (0.72, 0.95)

1.00
0.77 (0.57, 1.04)

Ever received HPV shot/vaccine
Yes
No

1.00
0.76** (0.63, 0.91)

Age when first child born
Never gave birth
<21 years
21-29 years
>=30 years

1.00
1.45*** (1.23, 1.71)
1.46*** (1.26, 1.68)
1.85*** (1.52, 2.24)

1.00
2.69*** (1.79, 4.02)
2.32*** (1.62, 3.33)
2.87*** (1.86, 4.41)

1.00
0.93 (0.79, 1.08)

1.00
0.51** (0.31, 0.83)

Currently taking birth control pills,
implants, or shots
Yes
No
Alcohol drinking status
Lifetime abstainer
Former drinker
Current drinker

-

1.00
1.01 (0.67, 1.52)
1.63** (1.15, 2.31)
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Smoking status
Never smoker
Former smoker
Current smoker
Flu shot past 12 months
Yes
No
Reported health status
Excellent, very good, or good
Fair or poor

1.00
1.06 (0.75, 1.50)
0.53*** (0.38, 0.73)

1.00
0.83** (0.74, 0.94)

1.00
0.52*** (0.39, 0.70)

1.00
1.19 (0.97, 1.45)

1.00
0.68* (0.47, 0.99)
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Table 3.3: Reasons why cervical cancer screening not obtained after physician recommendation
Reasons
No reason/never thought about it
Didn't need it/didn't know needed it
No problems
Put it off
Too expensive, no insurance
Too painful, embarrassing
Other

Frequency
144
39
37
39
73
23
37

Weighted Frequency
898,715
369,787
230,950
296,063
498,239
145,887
206,079
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Sample %
33.97
13.98
8.73
11.19
18.83
5.51
7.79

95% Confidence Interval
29.11
38.83
10.28
17.68
5.99
11.47
8.89
13.49
13.43
24.23
2.97
8.06
5.11
10.47

VII.
CONCLUSION

The purpose of this research was to: Describe predictors for cervical cancer
screening adherence using current guidelines among a sample of nationally representative
women; assess the association of marital status with cervical cancer screening adherence;
and explore the gap between physician recommendation of cervical cancer screening and
adherence to physician recommendation.
The results of this study indicate about 1 in 5 women in the United States are not
being screened for cervical cancer as recommended. Furthermore, the results suggest that
interventions to improve screening should be targeted to women under 30 and over 40
years of age, unmarried women, women who do not work, uninsured women, women
with no usual source of care, and current smokers.
Women who were married had increased odds of adherence with cervical cancer
screening recommendations compared to women in other marital categories. The
findings of this study are important because few studies have explored the effect of
marital status on cervical cancer screening adherence in the United States.
Cervical cancer screening rates for unmarried women are lower than those among
married women. Unmarried women would benefit from targeted interventions to
improve their screening rates. Physicians, regardless of their specialty, who are
examining or treating unmarried women should take the opportunity to educate them
about screening guidelines.
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A strategy to further increase cervical cancer screening rates nationally is for
physicians to recommend screening to all patients who might benefit. Physician
recommendation plays an important role in adherence to cervical cancer screening.
While most studies look at lack of adherence to cervical cancer screening after physician
recommendation, our study examines who does follow their physician recommendations
for cervical cancer screening. The results of this study will allow physicians and
policymakers to target women who are less likely to adhere to cervical cancer screening
recommendations.

Limitations
Limitations of this study included self-reported data, which may not accurately
capture cervical cancer screening adherence as a result of recall bias, social desirability,
and over-reporting of Pap test utilization. Women may also erroneously believe their
pelvic exam included a Pap test. Also, women who have multiple doctors’ appointments
may not recall what occurred at each appointment. Women who know the screening
recommendations but chose not to adhere may respond favorably to having received a
recent Pap test, even if they did not have one. In addition, self-report does not allow us to
explore physician barriers to understand why physicians may have been more likely to
recommend or not recommend screening.
Face-to-face interviews are conducted in respondents’ homes. Telephone
interviews are permitted if follow-ups to complete interviews are needed, the respondent
requests a telephone interview, or when road conditions or travel distances are a barrier to
to scheduling a visit before the completion date. NHIS asks respondents to provide
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residential telephone numbers, to allow recontacting of survey participants. The NHIS
survey is administered to people with landline telephones. Therefore, there may be
undercoverage due to not being able to reach persons with landline telephones. Results
from an NHIS survey suggested an increasing trend with Americans who only have
wireless telephones. Even those who have a landline may be difficult to reach due to a
wireless telephone being their primary mode of communication (Blumberg & Lake,
2017).
Missing data was not included in this study. Missing data can reduce statistical
power, cause bias in parameter estimations, and can reduce the sample’s
representativeness. However, less than 10% was missing from each variable.

Directions for future research
Despite these limitations, our findings suggest important considerations for
cervical cancer screening program planning and further research. Future research should
review barriers to screening in more detail. Health promotion programs should consider
addressing multiple prevention behaviors simultaneously. For example, our findings
consistently showed receiving a flu shot to be a significant predictor of cervical cancer
screening. Healthcare providers who administer flu shots may have an opportunity to
educate patients of other preventive behaviors.
Public health interventions targeting unmarried women are needed to promote
cervical cancer screening. Future studies should explore opportunities, such as physician
recommendations, to introduce unmarried women to the benefits of adhering to screening
recommendation.
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Strategies to address the reasons for non-adherence to cervical cancer screening
are needed, such as sensitivity training for physicians on delivering cervical cancer
screening recommendations and performing the tests. In addition, open communications
about sexual health are needed to address any misconceptions about the risk of cervical
cancer. Comprehensive communication that includes cervical cancer screening
recommendations and sexual health may have a positive impact on screening adherence.
Positive communications can lead to changes in health behavior, adherence to medical
advice, increased understanding about the importance of screening, and higher
satisfaction with care, which can lead to increased cancer screening rates. Future studies
should examine various mechanisms for physician recommendations to determine
feasible and cost-effective ways to increase recommendations and adherence to the
recommendations.
Future research should also consider self-collected HPV testing for women nonadherent to cervical cancer screening. Some studies have shown participation of underscreened women can be improved by offering HPV self-testing at home. Women have
expressed positive acceptance due to the elimination of logistical barriers, such as lack of
time or transportation to a health center, and avoidance of psychological barriers, such as
embarrassment and stress of undergoing cervical cancer screening (Katz, Zimmermann,
Moore, Paskett, & Reiter, 2016; Mao et al., 2017). While it can only be used for testing
by clinically validated assays and not cytological analyses, offering self-sampling devices
to non-adherent women can increase screening participation (Mistro et al., 2017). Home
HPV screening tests may be more widely accepted by both patients and physicians if it
does not impact access to a physician to address other health concerns (Mao et al., 2017).
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